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Abstract 
 
The object of this thesis, is to demonstrate the potential capabilities of injection 
moulded chiral plasmonic nanostructures for enhanced sensing in biological systems. 
The key phenomenon employed throughout this thesis is the generation of 
electromagnetic fields, that produce a greater chiral asymmetry than that of circularly 
polarised light, termed ‘superchiral’ fields. These superchiral fields will be 
demonstrated as being an incisive probe into the structure, conformation, and 
orientation of proteins immobilised on the nanostructure surface of these injection 
moulded substrates. Initially, it will be shown how this phenomenon is sensitive to 
higher order changes in protein structure induced upon ligand binding, using an 
asymmetry parameter extracted from the optical rotatory dispersion (ORD) spectra. 
Where these changes would not be routinely detected by conventional chiroptical 
spectroscopy techniques, such as circular dichroism (CD). Further to this, as these 
nanostructures display the plasmonic analogue of the interference effect, 
electromagnetically induced transparency (EIT), a narrow transparency window is 
created within a broad reflectance spectrum. Where the spectra can be modelled 
using a simple coupled oscillator model, and the retardation phase effects extracted. 
This allows two new asymmetry parameters to be introduced for characterising any 
changes induced by the biological samples, the experimental separation parameter 
∆∆𝑆, and the modelled retardation phase asymmetries. These will be used to 
characterise the orientation of three structurally similar protein fragments, called 
Affimers, with the modelled phase asymmetries being shown as a particularly incisive 
probe into the surface immobilised orientation. Furthermore, conformational changes 
in the cancer relevant protein, HSP90, will be characterised upon the addition of 
increasing concentrations of the inhibitor molecule 17-AAG. With the orientation of 
the immobilised HSP90 protein being shown to influence the sensitivity observed for 
any protein-ligand interactions that occur. Finally, this phenomenon will be used to 
quantitatively detect elevated protein levels in a complex solution. Elevated levels of 
IgG will be measured in human blood serum solutions, utilising the isoelectric point of 
the proteins in solution to enhance the level of IgG adsorbed in the protein corona. 
This will demonstrate for the first time, the use of superchiral fields generated around 
injection moulded chiral nanostructures, to detect protein changes in complex real life 
solutions, such as human blood serum. Representing the first step in creating a high-
throughput ultrasensitive system for a range of diagnostic applications.  
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Chapter 1: Introduction 
1.1 Thesis Overview 
Metamaterials are artificially structured materials comprised of individual structures 
much smaller than the wavelength of light [1]. In contrast to bulk materials, where the 
properties are determined by the intrinsic chemical constituents of the system, 
metamaterials rely on the specific structures created within the material. With the 
optical properties of the material being controlled by the size, shape, and arrangement 
of the constituent structures [2, 3]. Allowing these materials to manipulate 
electromagnetic (EM) waves in interesting ways, and produce properties that would 
not be achievable from bulk materials [4]. 
Throughout this thesis, we will be utilising injection moulded substrates as a high-
throughput method of characterising and detecting changes in biological systems, 
such as protein structural changes. Previously, chiroptical spectroscopies, such as 
circular dichroism (CD) and optical rotation (OR), have been used to probe chirality 
and orders of structure within biological samples. However, the low sensitivity of these 
methods has limited their use when measuring samples of increasingly small 
concentrations. More recently, chiroptical spectroscopy has attracted further interest 
when it was theorised that electromagnetic fields could exist that produce a greater 
chiral asymmetry than that of circularly polarised light (CPL), termed ‘superchiral’ [5]. 
It was then theorised that these superchiral fields could be significantly more sensitive 
to the structure of biological molecules compared with circularly polarised light, and 
could increase the sensitivity of chirally sensitive spectroscopy techniques. 
Experimentally, spectroscopic measurements that exploited these fields of enhanced 
chirality were first demonstrated by Hendry et al. in 2010, where they showed that 
chiral electromagnetic fields generated around chiral gold nanostructures were 
sensitive to different structural motifs in proteins [6]. Additionally, these experimental 
results also reported that the sensitivity of these generated chiral fields were 
enhanced by six orders of magnitude, relative to conventional chiroptical techniques, 
with the ability to detect picogram quantities of protein. 
In the first results chapter, chapter 4, we use these injection moulded chiral substrates 
to further investigate the chiral field enhancement reported in previous studies [6]. 
Two proteins from the Shikimate pathway, a seven step metabolic pathway found in 
plants and bacteria, are investigated due to each protein having well characterised 
higher order structural changes upon specific ligand binding. Optical rotatory 
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dispersion (ORD) spectra are measured from the chiral nanostructures, with the same 
∆∆𝜆 parameter introduced in the original experimental study being used to 
characterise the changes observed. This parameter essentially measures the 
changes in the effective refractive index on the asymmetry of the generated chiral 
fields around the nanostructures. Hence, the basis of ‘superchiral polarimetry’ 
employed here, is the spectral position dependence of the plasmonic resonance on 
the dielectric environment around the nanostructure surface. Conventional chiroptical 
spectroscopy, such as circular dichroism (CD), can routinely only detect changes in 
the secondary and, to a limited extent, tertiary structure of proteins. The two proteins 
investigated in this chapter, both undergo changes in the higher order structure upon 
ligand binding, with CD measurements recorded for each protein showing no 
sensitivity to these changes. However, we demonstrate that superchiral polarimetry 
is sensitive to the higher order structural changes induced within both proteins, due 
to the anisotropy of the protein structure, in agreement with the early published results 
using this property to discriminate between proteins with high α-helical content, or 
high β-sheet content [6].  
The detection of conformational changes in higher order protein structure, using ORD 
spectra from the chiral nanostructures, relies on an interpretation based on changes 
in the effective refractive index on the asymmetry of the generated chiral fields. This 
is a rather simplistic interpretation of the data used to characterise protein structural 
differences, and when examined theoretically, produces much smaller changes than 
are observed from the experimental results [7]. This shows that there may be other 
factors that lead to the significant sensitivity enhancement that is observed. In 
chapters 5, 6, and 7, we will move away from the more simplistic ORD interpretation 
seen in chapter 4, and develop a greater understanding of the chiral nanostructures 
by recording reflectance measurements for each experiment. When reflectance 
spectra are recorded from the chiral nanostructures used throughout this thesis, an 
electromagnetically induced transparency (EIT) like behaviour occurs. EIT is a 
quantum interference effect that appears in atomic systems consisting of three levels, 
resulting in a sharp transmission window within a broad reflection or absorption band. 
However, the plasmonic analogue of EIT derives from the strong coupling between 
bright and dark modes of the structure, to create a narrow transparency window within 
a broad reflectance spectrum [8-10]. With the strength of this coupling affecting the 
optical properties of the metamaterial. 
In chapters 5, 6, and 7, a new parameter will be introduced to characterise the 
changes that occur in the optical spectra, as a result of biological samples being 
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introduced to the nanostructure surface. This parameter ∆∆𝑆, the change in the 
separation of the reflectance dips separated by the narrow transparency window, 
essentially measures the asymmetry in the coupling of the two plasmonic modes for 
the chiral nanostructures. In chapter 5, three biological molecules consisting of the 
same protein scaffold, called Affimers, were immobilised on the nanostructure surface 
with three different well-defined orientations. We show that one of the orientations 
can be easily distinguished using the experimental ∆∆𝑆 parameter, but the other two 
orientations produce similar responses to each other, and therefore cannot be easily 
differentiated. However, a simple coupled oscillator model can then be introduced to 
theoretically model the experimental reflectance spectra for each measurement. This 
coupled oscillator model considers the coupling between the two oscillators, as well 
as the phase of the bright and dark oscillator, 𝜃 and 𝜙 respectively. The coupling of 
the two oscillators is related to the ∆∆𝑆 parameter measured experimentally, but has 
a much higher inherent error. However, asymmetries in the two theoretical phase 
parameters, ∆∆𝜃 and ∆∆𝜙, do show differences relative to the orientation of the 
biomaterial at the surface. With all three orientations of the Affimer proteins becoming 
easily distinguishable, when measuring retardation phase changes in the model 
values. Showing that the retardation phase changes are an incisive probe into the 
orientation of biomolecules at the nanostructured surface. 
In chapter 6, both the experimental ΔΔ𝑆,  and the two theoretical phase parameter 
asymmetries are used to detect ligand binding and conformational changes induced 
upon the cancer relevant protein, Heat shock protein 90 (HSP90). By attaching this 
protein to the nanostructure surface with two different immobilised orientations, and 
increasing the concentration of the inhibitor ligand introduced, a fingerprint of the 
protein-ligand interactions can be obtained. With the orientation of this immobilised 
protein being shown to affect the sensitivity of the phenomena to any ligand induced 
changes at low concentrations. Here, the experimental ∆∆𝑆 parameter, and the 
modelled phase asymmetry parameters are shown to be in good agreement with each 
other, validating the sensitivity of the measurement. With the modelled phase 
parameters being shown to be a slightly more incisive probe into the conformational 
changes that occur, for both orientations of the HSP90 protein, upon the addition of 
increasing concentrations of the inhibitor ligand, 17-AAG. 
Finally, in chapter 7, we will examine how small concentration changes of specific 
proteins in human blood serum, can affect the structure and composition of the protein 
corona at the nanostructured surface. The ∆∆𝑆 parameter will be used to 
experimentally measure the effect of increasing the immunoglobulin G (IgG) 
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concentration within human blood serum solutions. It will be shown that when the 
stock serum solution is diluted in a standard buffer, both low and high elevated levels 
of IgG in the solution will exhibit the same response. Resulting in various levels of 
elevated IgG spiked serums being indistinguishable from each other, due to the 
composition of the protein corona at the nanostructured surface. To resolve this issue, 
the effect of increasing the ionic strength of the dilution buffer was investigated. This 
would increase the electrostatic screening in the solution, and will be shown to lower 
the coverage of the protein corona on the plasmonic surface. Overall, increasing the 
ionic strength of the dilution buffer for the spiked serum solutions will be shown to 
increase the detection limit for elevated IgG levels, due to the lower corona coverage, 
into the physiologically relevant range required in clinical applications. This 
represents the first step in creating a commercially viable, high-throughput biosensing 
system, utilising the effects of chiral molecules upon the superchiral fields generated 
in chiral metamaterials. Although this is an early stage investigation into these effects, 
results from a complex system (such as human blood serum solutions) shown here, 
already demonstrate the potential of this phenomenon at probing the biological 
structure and composition at metamaterial surfaces. 
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Chapter 2: Theory 
2.1 Chirality 
When Pasteur first postulated the concept of chirality in 1848, he used the term 
‘dissymmetry’ to describe objects ‘which differ only as an image in a mirror, differs 
from the object that produces it’. The word ‘dissymmetry’ has more recently been 
replaced by ‘chirality’ and was first used in this context by Lord Kelvin at the University 
of Glasgow in 1904. As such, the modern definition of chirality given by Barron, in 
terms of group theory, states that the criteria “for an object to be chiral is that it must 
not possess improper rotation symmetry elements such as a centre of inversion, 
reflection planes or rotation-reflection axes” and so must belong to one of the point 
groups Cn, Dn, O, T or I [1]. Chirality is not only limited to objects however, and can 
also be seen in electromagnetics such as circularly polarised light, where the electric 
field vector of the light rotates either clockwise (right handed) or anticlockwise (left 
handed) around the axis of propagation and constitutes a helical pattern. 
 
2.1.1 Molecular Chirality 
Ever since Pasteur’s discovery of right- and left-handed crystals derived from tartaric 
acid, the interest in molecular chirality has continued to grow [1-3]. Molecules of 
opposite chirality, called enantiomers, are identical in most regards (e.g. density and 
molecular weight), however the handedness of a molecule can have an effect on 
some of its properties; such as odour, potency, and toxicity [4]. In nature most 
biological molecules which are chiral are found exclusively as one enantiomer, with 
natural sugars being exclusively right handed and all amino acids (except Glycine, 
which is not chiral) being exclusively left handed [5]. This homochirality in nature is of 
particular importance, due to the fact that the handedness of a molecule strongly 
affects how it interacts with other chiral molecules. This has played a significant role 
in drug discovery, as one enantiomer of the drug can have a drastically different effect 
to the other enantiomer, often with one having therapeutic activity and the other 
causing serious side effects [6, 7]. With most drugs being synthesised as a racemic 
mixture, it has become ever important to differentiate these molecules by their 
respective enantiomers. This can be achieved using another property possessed by 
molecules of different chirality, called optical activity. 
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2.2 Optical Activity 
Natural optical activity can be defined as a system which has a differential response 
to left- and right- circularly polarised light (CPL), without influence from external forces 
such as an applied magnetic field [1]. Natural optical activity can then also be broken 
down into electronic optical activity and vibrational optical activity. Where electronic 
optical activity enables the measurement of circular dichroism (CD) and optical 
rotation (OR), and vibrational optical activity gives rise to infrared (IR) measurements 
and Raman optical activity (ROA). All of the spectroscopic measurements performed 
throughout this thesis rely on electronic natural optical activity, so vibrational optical 
activity will not be discussed further in this thesis. 
For circularly polarised light, the tip of the electric field vector produces a circle with 
time, perpendicular to the axis of propagation. This circular polarisation is said to be 
right-handed if the electric field vector rotates clockwise when looking towards the 
source of light, and left-handed when the electric field vector rotates anticlockwise. 
 
Figure 2.01 Electric field vectors of circularly polarised light propagating along z. Vectors 
rotate clockwise when viewed in the -z direction showing right-handed polarisation. 
 
2.2.1 Optical Rotation 
From this definition of circularly polarised light, linearly polarised light can be regarded 
as a superposition of equal amplitude left- and right-circularly polarised light, where 
the orientation of the plane of polarisation is a function of the relative phases of both 
component beams. When linearly polarised light propagates through an optically 
active medium, the two circular components (left- and right-handed CPL) travel at 
different velocities. This difference in velocities of the two components would 
introduce a phase difference between them, and this would change the orientation of 
the plane of polarisation, α (Figure 2.02). If the medium was not optically active (e.g. 
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an achiral medium) the polarisation of the linear light beam would remain unchanged, 
as there would be no difference in the velocities of the left- and right-circularly 
polarised components, and therefore no phase difference between them. 
 
Figure 2.02 (a) Electric field vector of linearly polarised light split into the two components of 
left- and right-circularly polarised light propagating out of the page, (b) electric field vector 
rotated at a further point of propagation though an optically active medium. 
 
The rotation of the polarisation of a linearly polarised light beam gives rise to the effect 
known as optical rotation. When a linearly polarised light beam of angular frequency 
𝜔 = 2𝜋𝑐/𝜆 enters a transparent optically active medium at point z = 0, then at any 
given instant EL and ER are the same angle from the plane of propagation at that 
point, z = 0 (Figure 2.02(a)). Then at the same instant, at some point z = l, in the 
optically active medium, the electric field vectors EL and ER are orientated at angles: 
𝜃𝐿 = 2𝜋𝑐𝑙/𝜆𝑣𝐿 
𝜃𝑅 = 2𝜋𝑐𝑙/𝜆𝑣𝑅 
These changes are for EL and ER respectively from E at z = 0, as shown in Figure 
2.02(b), where 𝑣𝐿 and 𝑣𝑅 are the velocities of the left- and right-circularly polarised 
components within the medium. The angle of rotation of the linearly polarised light 
beam, in radians, becomes: 
𝛼 =  
1
2
(𝜃𝐿 + 𝜃𝑅) =  
𝜋𝑐𝑙
𝜆
 (
1
𝑣𝐿
−  
1
𝑣𝑅
) 
 
(2.2.1) 
(2.2.2) 
(2.2.3) 
9 
 
As the refractive index is 𝑛 = 𝑐/𝑣, the angle of rotation per unit length in equation 
2.2.3 can be written as: 
𝛼 =  
𝜋
𝜆
 (𝑛𝐿 −  𝑛𝑅) 
This optical rotation, the difference between the refractive indices 𝑛𝐿 and 𝑛𝑅 for left- 
and right-circularly polarised light respectively in the medium, is a function of circular 
birefringence. When this occurs, if the medium rotates the plane of polarization 
clockwise when looking towards the source of the light (as occurs in Figure 2.02(b)) 
the medium is classed as dextro rotatory, and if it rotates the plane of polarisation 
anticlockwise then it is said to be laevo rotatory. 
 
2.2.2 Circular Dichroism 
In an optically active medium, since the refractive index is different for both EL and ER 
in transparent media, then the absorbance of left- and right-handed circularly 
polarised light will also be different. Thus, this differential absorption of left- and right-
circularly polarised light is known as circular dichroism (CD).  
 
Figure 2.03 (a) Electric field vector of linearly polarised light split into the two components of 
left- and right-circularly polarised light propagating out of the page, (b) differential absorption 
of left- and right-CPL causing elliptically polarised light, specified by angle 𝜑. 
 
(2.2.4) 
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For circular dichroism, linearly polarised light is no longer rotated, like in optical 
rotation, but it becomes elliptically polarised due to the differential absorption of the 
left- and right-circularly polarised light. This differential absorption causes EL and ER 
to become two different amplitudes, which no longer combine to generate linearly 
polarised light, but create the elliptical polarisation as shown in Figure 2.03(b). The 
ellipticity (𝜑) can be calculated from the ratio of the minor and major axes of the ellipse 
as such: 
tan 𝜑 =  
(𝐸𝑅 −  𝐸𝐿)
(𝐸𝑅 +  𝐸𝐿)
 
For ellipticity, when the amplitude of ER is greater than EL, it is defined as positive, as 
a clockwise rotation of the electric field vector of the elliptically polarised beam occurs. 
Ellipticity is often the unit used when describing CD spectra, however the CD signals 
are usually very small with most proteins and biological samples showing ellipticities 
in the range of 10 millidegrees. Other than ellipticity, CD can also be quantified as the 
differential absorption of EL and ER where 𝐴 =  log
𝐼0
𝐼𝑙
=  𝜖𝑐𝑙 and is typically around    
10-3 absorbance units for protein samples [8, 9]. 
 
2.2.3 Optical Rotatory Dispersion 
Most applications of optical rotation use the rotation at some transparent wavelength, 
usually the sodium D line at 589 nm. However, optical rotatory dispersion (ORD) also 
exists, and measures the unequal rotation of polarisation at different wavelengths. 
Since both refraction and absorption are related, circular dichroism and optical 
rotatory dispersion have wavelength dependent spectra that are very close to 
conventional absorption and refraction. These related spectra for circular dichroism 
and optical rotatory dispersion in the absorption region are shown in Figure 2.04, and 
are related together by something known as the Cotton effect. From this relationship, 
the maximum ellipticity coincides with the optical rotatory dispersion curve at its point 
of inflection. For optically pure enantiomers, the Cotton effect ORD spectra are always 
opposite to each other but of equal magnitude. 
 
(2.2.5) 
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Figure 2.04 Ellipticity and related optical rotatory dispersion curves centred around the 
electronic absorption wavelength 𝜆𝑗.  
 
With the Cotton effect, the ellipticity and optical rotatory dispersion always have 
relative signs to each other, where a positive Cotton effect is seen when the ORD 
spectra rises to a peak at higher wavelengths and a trough at lower wavelengths 
(shown in Figure 2.04), and a negative Cotton effect when the ORD spectra is 
reversed. This is due to the fact that CD and ORD can be related to each other by a 
Kramers-Kronig (KK) relation [10], resulting in the relationship seen in Figure 2.04. 
 
2.3 Superchirality 
2.3.1 Superchiral Fields 
Chiral light-matter interactions are relatively weak, as shown for circular dichroism 
spectroscopy, where absorption differences are typically <10-3. This can be thought 
of as a consequence of the mismatch between the helical pitch of circularly polarised 
light, and the relatively small size of chiral molecules such as proteins. The circularly 
polarised wave has a helicity that depends upon the wavelength of the light, so that 
the circularly polarised field rotates a full 360o in one wavelength (typically a few 
hundred nanometres for UV/Visible light). This is considerably larger than the size of 
chiral molecules (around the tens of nanometres) so the circularly polarised field 
undergoes a barely perceptible twist over the distance of molecular dimensions [11]. 
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In recent years, it was recognised that an enhanced dissymmetry should occur if the 
field lines were reoriented over a distance that is much shorter than the wavelength, 
ideally close to the dimensions of molecules [12, 13]. When this occurs, the spatial 
scale of molecular chirality and the chirality of the light would match. It was identified 
that chiral interactions required a time-even pseudoscalar to fully describe the chirality 
of electromagnetic fields. In 1964, Lipkin introduced a series of conserved quantities, 
which he called ‘zilch’, to describe electromagnetic waves in a vacuum [14]. However, 
these quantities were dismissed as having no physical significance by both Lipkin, 
and others after him [15, 16]. It has since been realised that one of these quantities 
satisfies the need for a time-even pseudoscalar, and has been termed optical chirality, 
𝐶 [12]. 
𝐶 =  
𝜀0
2
𝑬 ∙ ∇×𝐄 + 
1
2𝜇0
𝑩 ∙ ∇×𝑩 
Where 𝜀0 and 𝜇0 are the permittivity and permeability of free space respectively, and 
𝑬 and 𝑩 are the time-dependent electric and magnetic fields. This optical chirality 
parameter captures the degree to which the electric and magnetic field vectors, 𝑬 and 
𝑩, wrap around a helical axis at each point in space, i.e. the tightness of the helix. In 
circular dichroism, the dissymmetry factor, 𝑔, is a dimensionless quantity that 
measures the enantioselectivity of a system [17]: 
𝑔 =  
𝐴𝐿 −  𝐴𝑅
1
2
(𝐴𝐿 +  𝐴𝑅)
 
Where the superscripts L and R refer to left- and right-circularly polarised light 
respectively. This dissymmetry factor, 𝑔, was then rewritten to include the optical 
chirality parameter, 𝐶 [12, 13]: 
𝑔 =  𝑔𝐶𝑃𝐿 (
𝑐𝐶
2𝑈𝑒𝜔
) 
Where 𝑔𝐶𝑃𝐿 is the dissymmetry factor under circularly polarised light, 𝑐 is the speed 
of light, 𝐶 is the optical chirality, 𝑈𝑒 is the local electric energy density, and 𝜔 is the 
angular frequency. Equation 2.3.3 shows that, unlike circular dichroism, the 
magnitude of the dissymmetry factor, 𝑔, is dependent on the optical chirality, 𝐶, and 
not solely governed by the chirality of matter. Since the field vectors completely rotate 
once per wavelength at a constant rate for circularly polarised light, the quantity 
𝑐𝐶/2𝑈𝑒𝜔 equals 1. Therefore, to increase the dissymmetry factor an increase in the 
(2.3.1) 
(2.3.2) 
(2.3.3) 
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optical chirality, 𝐶, leading to the quantity 𝑐𝐶/2𝑈𝑒𝜔 being greater than 1 in some 
regions of space would be necessary. When this occurs, these fields have been 
termed as ‘superchiral’ fields, as they have a much greater helicity than that of 
circularly polarised light.  
The first time that these ‘superchiral’ fields were produced was by creating an optical 
standing wave constructed of two counter propagating waves of circularly polarised 
light with opposite handedness, equal frequency, and a slightly different intensity. This 
was generated by reflecting circularly polarised light of one handedness off of a 
partially reflecting mirror at normal incidence, which creates the perfect conditions to 
generate ‘superchirality’ [12]. Now, the most common and simplest way to get an 
enhancement of the optical chirality, 𝐶, is through the use of plasmonic 
nanostructures [18-22]. By using plasmonic nanostructures, strong electric and 
magnetic fields in the near field of the nanostructure can be created using visible/IR 
radiation. To get the optimum enhanced optical chirality, 𝐶, over a continuous region 
it has been shown that the nanostructures must be designed to optimise this 
parameter by using planar chiral nanostructures, ideally without sharp corners [19]. 
The first experiment to utilise this theory of ‘superchiral’ fields, by using chiral 
gammadion nanostructures, showed a dissymmetry enhancement of ~106 when 
detecting biomolecules, compared with using circularly polarised light alone for 
biomolecular detection [18]. 
 
2.4 Plasmonics 
2.4.1 Plasmonic Oscillations 
Plasmonic oscillations can occur in metallic thin films (at metal-dielectric interfaces) 
[23], and metallic nanostructures [24], typically made of gold or silver. This is due to 
the large distance between the valence electrons and positive core of a metal ion, 
causing them to be weakly bound to each other. When these atoms come together to 
form a thin film or nanoparticle, the valence electrons are influenced by the potential 
energy of all other atoms in the system. This allows the valence electrons to freely 
move throughout the system around a background of positive ion cores, essentially 
generating an electron cloud or plasma. These electrons move throughout the entire 
system in a random motion and keep the overall charge of the system at 0. When an 
electric field is applied to the system, the electron plasma is displaced by a distance, 
x, Figure 2.05(b). 
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Figure 2.05 Graphical representation of plasmonic oscillations. (a) bulk metal with no electric 
charge applied, (b) shows after application of an electric field causing displacement of the 
electron cloud, (c) shows oscillation of electron cloud in opposite direction when electric field 
turned off. 
 
When the external electric field is switched off, the electrons in the metal will be 
accelerated by the surface charges created back to their original position. Once they 
have returned to their original positions (Figure 2.05(a)), they have acquired 
momentum and will then keep moving in the other direction to create an electric field 
of opposite sign from before, Figure 2.05(c). This will be repeated in each direction 
and hence produce a plasmonic oscillation with a plasma frequency, 𝜔𝑝 [25, 26]: 
𝜔𝑝
2 =  
𝑛𝑒2
𝑚𝜀0
 
Where 𝑛 is valence electron density, 𝑒 is the charge of an electron, 𝑚 mass of an 
electron, and 𝜀0 is the permittivity of free space. This collective oscillation can then 
be thought of as an oscillation that is produced by an electric field, due to all the 
electrons in the system, called a bulk plasmon, as it is throughout the bulk material. 
 
2.4.2 Surface Plasmon Polaritons 
Surface plasmon polaritons (SPP) are electromagnetic excitations that propagate 
along a metal-dielectric interface, and are evanescently confined in the perpendicular 
direction. These electromagnetic surface waves occur via the coupling of the 
electromagnetic fields to the oscillating electron plasma of the metal [27]. This 
happens when an incident electromagnetic wave, creates a charge oscillation on the 
metal surface that propagates along the surface at the metal-dielectric interface. The 
(2.4.1) 
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collective oscillation of these surface charges excites the surface plasmon polaritons 
with a different frequency than the bulk plasma frequency seen in equation 2.4.1, and 
now becomes: 
𝜔𝑠𝑝𝑝 =  
𝜔𝑝
√1 +  𝜀𝑑
 
Where 𝜔𝑝 is the bulk plasma frequency, and 𝜀𝑑 is the relative permittivity of the 
dielectric. From this, it can be seen that the surface plasmon polariton frequency is 
lower than the bulk frequency, so can be excited at lower energies. 
 
Figure 2.06 Graphical representation of (a) the surface charges and resultant electromagnetic 
wave at the metal-dielectric interface, and (b) the electric field strength in the z direction for 
both the dielectric and metal. δd and δm are the penetration depths of the SPP wave into the 
dielectric and metal respectively. 
 
Once the surface plasmon polariton mode has been excited it will propagate along 
the metal surface, however it will gradually attenuate due to the losses arising from 
absorption in the metal. Therefore, the propagation length of the surface plasmon is 
limited by the internal damping of the metal, and is dependent on the dielectric 
constant of the metal and the incident wavelength of light. As a result of this surface 
propagating wave, associated non-propagating evanescent fields extend 
perpendicular to the surface into both the metal and the dielectric (Figure 2.06). The 
distance that these fields extend into the metal and dielectric both depend on the 
relative permittivities of the two interface materials, and decay exponentially with 
distance from the interface (Figure 2.06(b)). The distance that the evanescent fields 
extend can be thought of as penetration depths, 𝛿𝑚 and 𝛿𝑑, for the metal and dielectric 
respectively. For example, with gold and water as the metal and dielectric, the 
penetration depths with incident light at 630 nm are 29 nm for 𝛿𝑚 and 162 nm for 𝛿𝑑 
[28]. It can be seen that the penetration depth for the dielectric is much larger than for 
(2.4.2) 
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the metal, and as they decay exponentially are much more concentrated near to the 
interface. 
 
2.4.3 Plasmon Excitation  
For surface plasmon polaritons, the parameter of surface plasmon polariton 
dispersion can be obtained by solving Maxwell’s equations for the appropriate 
conditions to give [29]: 
𝑘𝑠𝑝𝑝 =  𝑘√
𝜀𝑑𝜀𝑚
𝜀𝑑 +  𝜀𝑚
 
Where 𝑘𝑠𝑝𝑝 is the wavevector of the surface plasmon, 𝑘 is the wavevector of a photon 
in free space, and 𝜀𝑑 and 𝜀𝑚 are the relative permittivities of the dielectric and the 
metal respectively. Typically, the square root term in equation 2.4.3 (√
𝜀𝑑𝜀𝑚
𝜀𝑑 +  𝜀𝑚⁄
) 
is positive and larger than 1, as 𝜀𝑚 must be large and negative, and 𝜀𝑑 must be small 
and positive for a surface plasmon resonance to exist, and is fulfilled at metal-
dielectric interfaces for visible frequencies [30]. For example, gold has a 𝜀𝑚 value at 
620 nm of -9.728 + i1.314, and silicon oxide has a 𝜀𝑑 value of 2.127 [31, 32]. From 
equation 2.4.3, it can be seen that the momentum of the surface plasmon polariton 
(𝜌 =  ħ𝑘𝑠𝑝𝑝) is larger than the momentum of light in free space (𝜌 =  ħ𝑘) at the same 
frequency, giving a mismatch in the momentum of the light and the surface plasmon 
polariton [29]. 
 
Figure 2.07 Dispersion curves for surface plasmon polariton, and light in a vacuum. 
Wavevector for SPP is always higher than for light at the same frequency. 
(2.4.3) 
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From this momentum mismatch, due to the wavevector of the SPP always being 
larger than the wavevector of a photon (Figure 2.07), light illuminating a smooth metal 
surface cannot be coupled to the surface polaritons directly. To combat this problem, 
the momentum of the light and surface plasmon polariton must be matched using 
prism couplers or grating features [33, 34]. The two most popular methods for prism 
coupling are the Kretschmann [35], and the Otto [36] configurations.  
 
Figure 2.08 Prism coupling methods of SPP excitation at a metal-dielectric interface. (a) 
Kretschmann configuration, and (b) Otto configuration. 
 
In the Kretschmann configuration, the incident light passes through a dielectric prism 
at an angle of incidence greater than that of total internal reflection. The wavevector 
of the light increases through the prism and tunnels through the metal film, where the 
light couples to the surface plasmon resonances. In the Otto configuration, the light 
from the prism tunnels through a small air gap between the prism and the metal, 
coupling to the SPP at that interface, so can be used for thicker metal films than the 
Kretschmann configuration. 
Using the same principles as the prism coupling, surface plasmons can also be 
coupled by using a diffraction grating to match the momentum of the light and the 
SPP. Some of the diffracted components of the light will match the wavevector of the 
SPP, and these can couple to give an excitation.  
 
2.4.4 Localised Surface Plasmon Resonances 
Similar to the surface plasmon oscillations that occur in metal films, at the metal-
dielectric interface, plasmon oscillations can also occur in metallic nanostructures and 
nanoparticles. Unlike the surface plasmons on the metal films, these localised surface 
plasmons can be excited directly through simple reflection. This is possible since the 
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plasmons are no longer propagating, so the momentum matching conditions for the 
surface plasmon is not required [37]. 
 
Figure 2.09 Graphical representation of localised surface plasmons on metallic nanospheres. 
 
Localised surface plasmons occur when incident light interacts with metallic 
nanoparticles (such as nanospheres) that are much smaller than the incident 
wavelength (Figure 2.09). Instead of these plasmons propagating along the surface 
of a metal film, the plasmons oscillate locally around the nanoparticle. This oscillation 
results in evanescent fields that extend around the nanoparticle surface into the 
dielectric environment, the same as for surface plasmons, however the decay length 
of these fields for localised surface plasmons can be 40-50 times shorter than that of 
SPPs [38]. These localised surface plasmon resonances, having such a short decay 
length from the nanoparticle, are sensitive to the dielectric constant or refractive index 
(𝜀 =  𝑛2) of the dielectric that surrounds them. So, by adsorbing a molecule or 
biomaterial to the surface of the nanoparticles, the position of the resonance would 
shift due to the change in the local environment around the metallic nanostructure. 
This shift can be calculated through: 
∆𝜆 = 𝑚𝛥𝑛 [1 − 𝑒𝑥𝑝 (−2𝑑 𝑙𝑑
⁄ )] 
Where 𝑚 is the bulk refractive index response of the nanoparticles, ∆𝑛 is the change 
in the refractive index from the adsorbate, 𝑑 is the thickness of the adsorbed layer, 
and 𝑙𝑑 is the evanescent field decay length. This relationship forms the basis of most 
LSPR shift sensors that use a wavelength shift for detection. However, the line shape 
and position of the LSPR spectra strongly depends on many factors, such as the 
material, shape, size, and local dielectric properties of the nanoparticles [39-41]. For 
(2.4.4) 
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example, where spherical nanoparticles will have only one resonance, metallic 
nanorods split the plasmon resonance into a low- and high-energy resonance. This 
occurs as the surface plasmons are unevenly distributed in nonspherical 
nanoparticles. So for the metallic nanorods, the high energy resonance corresponds 
to the plasmon oscillations in the direction perpendicular to the major axis (or 
transverse mode), while the lower energy resonance arises from the plasmon 
oscillations along the major axis (or longitudinal mode) of the nanorods [42]. 
 
2.4.5 Plasmonic Hybridisation 
The surface plasmon polariton (SPP) and localised surface plasmon (LSP) described 
in the previous sections have been for individual plasmon resonances. However, 
these plasmon resonances can essentially couple to each other when the 
nanostructures are in close enough proximity to each other, or aggregation of the 
nanoparticles begins to occur [43]. This electromagnetic coupling has previously been 
observed between metallic films-nanostructures [44], solid-solid structures [45], solid-
inverse structures [46], and inverse-inverse structures [47] within a plasmonic system. 
In all of these systems, it has been shown that the coupling of two (or more) plasmonic 
structures leads to hybridised plasmon modes. To characterise the hybridisation of 
these plasmon modes, a simple model was proposed where the plasmon coupling in 
metallic nanostructures could be thought of as an analogue to molecular orbital 
hybridisation [48]. A simple example of this hybridisation model, and one that has 
been demonstrated many times, is the dipole-dipole interactions between a metallic 
nanorod dimer [45, 49]. In this system when the gap between the two metallic 
nanorods becomes small enough to create overlap between the individual plasmon 
modes on each of the rods, in the longitudinal direction for Figure 2.10, there is a 
strong near field interaction between the nanoparticles. This interaction is the basis 
of the hybridisation of the plasmon modes on each individual particle, and forms the 
coupled modes over the whole structure. As shown in Figure 2.10, when the individual 
particles of the dimer couple to each other, they can couple to form both in-phase and 
out-of-phase combinations. 
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Figure 2.10 Hybridisation (energy level) diagram of two nanorods aligned longitudinally to 
each other and separated by a small gap. 
 
So, when the plasmon oscillations on each individual nanorod are in-phase with each 
other, along the aligned axis, then a symmetric mode occurs. Conversely, when the 
oscillations of the individual nanorods are 180o out-of-phase along the aligned axis, 
the anti-symmetric mode occurs. The molecular analogy used in this model means 
that these in-phase and out-of-phase modes correspond to the bonding and anti-
bonding orbitals respectively. Similar to the bonding and anti-bonding orbitals used in 
molecular orbitals, the in-phase and out-of-phase modes of the plasmon hybridisation 
model differ in energies. The in-phase (bonding) mode has a lower energy and an 
enhanced electromagnetic field in the gap between the two rods, whereas the out-of-
phase (anti-bonding) mode has a higher energy, and a negligible electromagnetic 
field in the gap between the nanorods [50]. The in-phase mode of the system typically 
has a large dipole moment, and interacts strongly with the incident light. However, 
the out-of-phase mode only has a small dipole moment as the dipoles in the individual 
nanoparticles are aligned anti-parallel. This out-of-phase mode, due to the small 
dipole moment, does not interact strongly with the incident light. As a result of this, 
the in-phase and out-of-phase modes are often called the bright and dark modes of 
the system. Although, this hybridisation model has been applied to simple structures, 
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such as the metallic nanorods, it can also be applied to more complex structures by 
analysing them in terms of their constituent parts (such as nanospheres, nanoshells, 
etc.) [48]. 
 
2.5 Interference Effects 
As mentioned in the previous section, and shown in Figure 2.10, the simple case of 
two metallic nanorods can couple to each other to form in-phase and out-of-phase 
plasmon modes. The in-phase mode, has a strong dipole moment and can interact 
directly with the incident light, whereas the out-of-phase mode has a negligible dipole 
moment and cannot interact directly with the incident radiation. These modes are 
often termed as the bright and dark modes of the system for this reason. To 
understand the interference effects within these systems, the simplest analogy is to 
relate the classical model of two coupled harmonic oscillators, driven by an external 
force, to the metamaterial systems [51]. 
 
Figure 2.11 Schematic of the coupled oscillator model between bright and dark modes. 
 
In this system, an external force (corresponding to the electromagnetic field) is 
applied to one of the oscillators. When the external force, F, is applied to the mass, 
m1, it begins to oscillate at the frequency, ω1. When the resonant frequencies of m1 
and m2 overlap, the oscillation of m1 caused by the external force will couple to the 
mass m2 and induce an oscillation with a frequency, ω2. This oscillation of m2 cannot 
be induced by the external force, but only by the oscillation of m1. This analogy 
corresponds to m1 being the in phase (bright) plasmon mode, and m2 being the out 
of phase (dark) plasmon mode. The generation of interference effects are highly 
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dependent on the relative phase of the coupled oscillators, where the phase 
difference of the two oscillators can be given by [52]: 
𝜑2 − 𝜑1 =  𝜋 − 𝜃 
where the extra phase shift, 𝜃, can be defined as: 
𝜃 =  tan−1 (
𝛾2𝜔
𝜔2
2 − 𝜔2
) 
Where 𝛾 is the damping parameter, 𝜔 is the frequency of the external force, and 𝜔2 
is the resonant frequency of the oscillator. From this it can be seen that a single forced 
oscillator has a 𝜋 change in phase when it goes through the resonance 𝜔2. This 
means that below the frequency, 𝜔2, the oscillator and the external force are in phase, 
whereas above the frequency, the oscillator and external force are out of phase with 
each other. For the two coupled oscillators, at the resonant frequency of the second 
oscillator, there are two forces acting upon the first oscillator. These two forces are 
out of phase to each other and would interfere destructively by cancelling each other 
out, which gives rise to the interference effects within the plasmonic structures [51]. 
 
2.5.1 Fano Resonance 
A common interference phenomena caused by this coupling of in-phase and out-of-
phase plasmon modes is Fano resonance. Fano resonances occur when there is 
constructive or destructive interference between a narrow discrete state and a broad 
resonance or continuum.  
 
Figure 2.12 Asymmetric Fano resonance produced from the coupling of optically bright and 
dark plasmon modes. 
(2.5.1) 
(2.5.2) 
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For plasmonic materials, broad and narrow resonances occur for all eigenmodes of 
the structures, and so satisfy the condition of a Fano resonance, where the broad and 
narrow resonances spectrally overlap [53]. Using the analogy of the two coupled 
nanorod dimers, the bonding mode, or bright mode, has a broadened resonance, and 
the anti-bonding mode, or dark mode, with no net dipole moment shows a sharp 
resonance that couple to each other to form the Fano resonance [54]. The Fano 
resonance, does not display the typical Lorentzian line shape seen for other 
resonances, but displays a more asymmetric line shape that can be seen in Figure 
2.12. With the line shape of the resonance defined by the function: 
𝐼 ∝  
(𝐹𝛾 + 𝜔 +  𝜔0)
2
(𝜔 − 𝜔0)2 +  𝛾2
 
where 𝜔0 and 𝛾 denote the position and line width of the resonance respectively, with 
F being the Fano parameter that describes the degree of asymmetry [54]. 
 
2.5.2 Electromagnetically Induced Transparency 
Electromagnetically induced transparency (EIT) is a quantum interference effect that 
allows the propagation of light through an atomic medium, and produces a narrow 
transparency window within an absorption peak [55]. A typical three level EIT system 
can be seen in Figure 2.13(a). 
 
Figure 2.13 (a) Three level EIT system where ωp and ωc are the frequency of the probe and 
coupling beams, and (b) EIT absorption spectra showing a narrow transparency dip within a 
broad absorption band. 
 
(2.5.3) 
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Requirements for EIT in a three-level system are that two of the possible transitions 
must be dipole allowed, and the other transition must be dipole forbidden, with one of 
the three states being connected to the other two by two optical fields, as shown in 
Figure 2.13(a). The system is irradiated with two beams, the probe beam and the 
coupled beam. The probe and coupled beams have frequencies 𝜔𝑝 and 𝜔𝑐 
respectively. When the system is irradiated with a probe beam that is tuned near to 
the resonance between two of the states, the absorption spectrum of that transition 
can be measured. However, when a coupling beam that is near the frequency of the 
resonance of the other dipole allowed transition is used, the transparency window can 
also be detected by the probe beam. In the three-level exemplar EIT system shown 
in Figure 2.13(a), the probe beam drives the coupling directly between the |0⟩ - |1⟩ 
pathway, and once the coupled beam is added, a second pathway occurs between 
|0⟩ - |1⟩ - |2⟩ - |1⟩. These two pathways interfere destructively with each other, and if 
energy level |2⟩ has a longer lifetime compared with the other levels, a transparency 
window appears completely within the absorption line, as shown in Figure 2.13(b) 
[56].  
 
2.5.3 Plasmonic Electromagnetically Induced Transparency 
For plasmonic electromagnetically induced transparency, instead of a three-level 
system, coherent coupling can occur between two resonances. These resonances 
can be thought of as the bright and dark resonances of the plasmonic system, like in 
the nanorod system in section 2.4.5. The bright mode of the system is typically a 
broad resonance with a large scattering cross section, and the dark mode a sharp 
resonance with a much larger quality factor. The dark mode of the plasmonic system 
is analogous to the metastable level |2⟩ in the atomic system. Therefore, when 
coupling of the bright and dark mode happens, destructive interference between the 
two modes occurs, and produces the induced transparency window within the 
absorption line. This is analogous to the atomic system as the two possible pathways 
that destructively interfere here are the direct excitation of the bright mode by the 
incident EM field, and the coupling between the bright and dark modes. The strength 
of the electromagnetically induced transparency depends on the spectral overlap of 
the resonances, and their coupling strength, where an increase in coupling between 
the resonances widens and deepens the transparency window [57]. This means the 
EIT spectra produced by these plasmonic systems can be modified and tuned by 
varying the coupling of these modes via structural tuning. These EIT like spectra 
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produced by plasmonic systems have been shown to have excellent potential for 
sensing applications, with some structures being shown to have refractive index 
sensitivity of ~ 588 nm/RIU [58]. 
 
2.5.4 Plasmonic EIT Modelling 
Plasmonic electromagnetically induced transparency can be modelled 
mathematically, to reproduce the spectra created from plasmonic EIT systems. A 
coupled oscillator model was first proposed by Zhang et al. [57], and variations of this 
approach have been used by Tassin et al. [59]. The model system used to fit the 
plasmonic EIT spectra can be described by a set of two coupled harmonic oscillators: 
𝜔𝑟
−2?̈?(𝑡) +  𝛾𝑟𝜔𝑟
−1?̇?(𝑡) +  𝑝(𝑡) =  𝑔𝑓(𝑡) − ?̃?𝑞(𝑡) 
𝜔𝑑
−2?̈?(𝑡) +  𝛾𝑑𝜔𝑑
−1?̇?(𝑡) +  𝑞(𝑡) =  −?̃?𝑝(𝑡) 
The radiative (bright) resonator is described by the excitation 𝑝(𝑡), with a resonance 
frequency 𝜔𝑟, and a damping factor 𝛾𝑟. Where the dark mode is described by the 
excitation 𝑞(𝑡), with a resonance frequency 𝜔𝑑, and a damping factor 𝛾𝑑. The two 
resonators are coupled by a complex coupling constant ?̃?, with the bright mode being 
driven by an external force 𝑓(𝑡), and a constant describing the coupling strength 
between the oscillator and the external force, 𝑔. In addition to some previous 
utilisations of this coupled oscillator model for plasmonic EIT, two terms are 
introduced in the solutions, 𝑒−𝑖𝜃 and 𝑒−𝑖𝜙. These terms account for any retardation 
phase shifts that occur in the bright and dark mode excitations, 𝜃 and 𝜙 respectively. 
Since both resonators are linearly coupled by the complex coupling coefficient ?̃? =
 𝑘𝑒−𝑖(𝜔𝑡), the solutions to equations 2.5.3 and 2.5.4 take the form: 
𝑝(𝑡) =  𝑒−𝑖𝜃𝑃(𝜔)𝑒−𝑖(𝜔𝑡) 
𝑞(𝑡) =  𝑒−𝑖𝜙𝑄(𝜔)𝑒−𝑖(𝜔𝑡) 
From these equations and using an effective medium approximation, an expression 
can be derived for fitting the reflectivity spectra obtained from plasmonic EIT systems, 
giving a deeper understanding of EIT metamaterials as a function of their microscopic 
parameters (Appendix A). This procedure for fitting plasmonic EIT reflectance spectra 
will be further developed throughout the experimental and results chapters of this 
thesis.  
(2.5.3) 
(2.5.4) 
(2.5.5) 
(2.5.6) 
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Chapter 3: Experimental 
3.1 Introduction 
This chapter provides a brief overview of the fabrication and experimental procedures 
employed throughout this thesis. This includes the fabrication of templated chiral 
substrates, and the experimental procedures and techniques for all spectroscopic 
measurements performed. Fabrication and characterisation of all samples were 
carried out in the James Watt Nanofabrication Centre, and the School of Engineering, 
at the University of Glasgow. With spectroscopic measurements for all experiments, 
and all protein purification being carried out in the School of Chemistry, at the 
University of Glasgow, unless otherwise stated. 
 
3.2 Nanostructure Fabrication 
3.2.1 Template Fabrication 
To create the templated plasmonic substrates (TPSs), an initial metal nanopatterned 
template must be created. This template (known as a shim) can then be used to 
replicate the nanostructures many times, using the high-throughput injection 
moulding technique. To ensure that the same shim can be used for multiple batches 
of substrates, over an extended period of time, it has to be cleaned and stored 
between runs. This is done by washing the shim in ethanol and isopropyl alcohol (IPA) 
sequentially, and then cleaning it with oxygen plasma before and after each use. The 
shim is then stored in a clean room environment when not in use. 
To fabricate the metal shim, the structures are first produced lithographically using 
electron beam lithography (EBL). Firstly, a silicon wafer is cleaned with several 
rounds of solvent washing (acetone, methanol, and IPA consecutively) and sonicated, 
and then dried under a constant stream of N2 gas. A poly(methyl methacrylate) 
(PMMA, Lucite International, MW = 2010) resist layer is then spin coated onto the 
surface of the wafer to a thickness of 100 nm. The substrate is then left to bake in a 
180oC oven for 5 minutes in order to evaporate any solvent. The nanopatterns are 
then written into the resist layer using an electron beam writer (Vistec VB6), and the 
substrate is developed using a 2.5:1 ratio of IPA and methyl isobutyl ketone (MIBK) 
for 60 seconds at 25oC. Once the resist has been developed, the substrate is 
electroplated with nickel (1mm), and acetone is then used to remove any remaining 
PMMA allowing the separation of the now nanopatterned nickel shim and the silicon 
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wafer. Nickel is used to fabricate the templated shim due to its low surface roughness, 
which limits the defects in the final injection moulded structures, and increases 
reproducibility [1]. 
 
Figure 3.01 Graphical description of nickel shim fabrication for injection moulding process. 
 
3.2.2 Injection Moulding 
All samples were injection moulded using an Engel Victory 28 hydraulic injection 
moulder, shown in Figure 3.02(a), and made using clear polycarbonate (Makrolon OD 
2015). The injection moulding process begins by fitting the nickel shim into the 
moulding tool and setting the appropriate parameters for flow and temperature of the 
polycarbonate. These parameters are vital to ensure that the polycarbonate flows 
completely over the templated shim, and ensures that all the features are replicated 
to a high quality. Stock polycarbonate beads, a few millimetres in diameter, are fed 
into the machine and heated to their melting point of 280oC, ready to be injected into 
the mould cavity. The process of creating the samples begins when the moving plate, 
containing the shim, moves towards the fixed plate and they lock together. The molten 
polymer is then injected under pressure into the cavity, at a constant rate, where the 
temperature is kept above the polymers glass transition temperature of 145oC. The 
molten polymer then rapidly cools upon contact with the nickel shim, reproducing the 
nanofeatures in a solid substrate surface. 
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Figure 3.02 (a) Picture of Engel Victory 28 injection moulder, (b) graphical description of the 
injection moulder tool showing the nickel shim within the moulding cavity, and (c) graphical 
description of the high-throughput injection moulding process for creating each templated 
substrate. 
 
The moving plate then retracts away from the fixed plate, allowing the solid polymer 
substrate to be retrieved from the tool. Once the sample is retrieved from the tool, the 
process (represented in Figure 3.02(c)) can be repeated as many times as necessary 
to create multiple replicates of the substrate. The whole process, from polymer 
injection to retrieval of the sample, is fully automated resulting in a high-throughput 
method of easily producing many identical substrates. A typical injection moulding 
session will produce upwards of 200 samples over approximately 2-3 hours, with one 
sample being produced every 20 seconds. 
 
3.2.3 TPS Preparation 
To complete the TPS process, each slide is rinsed with methanol and IPA 
consecutively, before being dried under a constant stream of nitrogen. The clean 
injection moulded slides (Figure 3.03 left) are then placed in an electron beam 
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evaporator (Plassys MEB-400s), where 100 ± 1.5 nm of gold is evaporated onto the 
substrate surface with a rate of ≈ 0.3 nm s-1 under a chamber pressure of 1x10-7 mbar. 
This creates the final gold coated TPSs, Figure 3.03 right, which are cleaned before 
each experiment in an oxygen plasma cleaner (Gala Instruments, Plasma Prep 5) for 
20 seconds at 160 W. 
 
Figure 3.03 Photo of injection moulded substrates before, and after 100 nm gold is evaporated 
onto the nanopatterned surface. 
 
3.2.4 Nanostructure Geometry 
As a result of the injection moulding process, the nanopatterned surface of the 
polymer substrates consists of periodic arrays of chiral indentations, Figure 3.04(a). 
The chiral nanostructure indentations that are produced for use in this thesis are all 
six-fold symmetric “Shuriken” structures. These structures consist of a central circular 
section, with six equally sized and spaced arms extending out from the centre in both 
a curved left- and right-handed fashion (Figure 3.04 (c)). The size of these 
indentations (after being coated with 100 nm of gold) are 500 nm in diameter, between 
the widest two points of the shuriken structure, with a periodicity of 700 nm (SEM in 
section 3.3). The thickness of the arms for each structure is 32 nm wide, and the 
indentations have a depth into the polymer substrate of 80 nm. The dimensions of the 
arrays for both left- and right-handed shuriken structures are 300 μm x 300 μm, with 
each array consisting of 430 shurikens along each side, giving a total number of 
184,470 shurikens per array. When the structures are coated with the 100 nm gold 
layer, the vertical side walls of the indentations are also completely covered. Resulting 
in a continuous gold film with periodic shuriken shaped indentations, containing a gold 
shuriken shaped structure at the base of these indentations (AFM data in section 3.3). 
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Figure 3.04 (a) Top and side view of shuriken indentation in injection moulded polymer 
substrate (80 nm depth), (b) shuriken indentations after evaporation with 100 nm gold, 
showing continuous gold film and indentations, and (c) SEM images of both right- (blue border) 
and left-handed (red border) shuriken structures with diameter of 500 nm and periodicity of 
700 nm. 
 
3.2.5 Nanostructure Hybridisation 
Since the metamaterial structures consist of a solid shuriken shaped nanostructure, 
and an identical shaped void above it, they can be considered as ‘hybrid’ structures 
(or solid-inverse structures). With the roles of electric and magnetic fields being 
switched between the solid and inverse structures [2]. The result of this, is that 
symmetry equivalent electric and magnetic modes of the solid and inverse structures 
are located directly above each other, leading to effective coupling between the 
modes. To understand the coupling between the electric and magnetic modes of the 
hybrid structures in Figure 3.04, a hybridisation scheme (which is analogous to a 
molecular orbital diagram) can be created [3]. Since the solid and inverse structures 
consist of the same shape, positioned directly above each other, the electric and 
magnetic modes are symmetry identical, and belong to the C6 point group. Hence, 
both modes belong to the A, B, E1, and E2 symmetry species (C6 character table in 
Appendix B). From the C6 character table, it can be seen that modes with A and E1 
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symmetry are optically bright since they have dipolar character, with only the E1 mode 
being accessible with the normal incident geometry used. There are also two optically 
dark modes, B and E2, however the lowest energy dark mode with quadrupolar 
character is E2. Hence, the hybrid shuriken structures possess a bright dipolar mode 
with E1 symmetry, and a dark quadrupolar mode with E2 symmetry. 
 
Figure 3.05 Hybridisation scheme between electric and magnetic modes of the shuriken 
nanostructures. Δ is the energy separation between the bright and dark modes. 
 
Figure 3.05 shows the hybridisation scheme for the hybrid shuriken structures. The 
hybridisation of the two modes, can generate in-phase (bonding) and out-of-phase 
(antibonding) hybrid modes, with the bonding modes having lower energy, as 
described in chapter 2. The in-phase and out-of-phase combinations for the dipole 
hybrid modes are labelled DE+M and DE-M respectively, with the similar quadrupole 
modes labelled QE+M and QE-M. The energy separation between the bright and dark 
modes, Δ, dictates the coupling between DE-M and QE+M. Hence, by controlling the 
coupling between the two modes, the optical properties of the structures can be 
controlled. With strong coupling within the hybrid structures, resulting in the 
interference effects described in Chapter 2, such as the plasmonic analogue of 
electromagnetically induced transparency [2]. 
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3.3 Structure Characterisation Microscopy 
3.3.1 Scanning Electron Microscopy (SEM) 
Scanning electron microscopy (SEM) is a type of electron microscopy that uses a 
focused beam of electrons to scan the surface of a sample, and create a detailed 
image. This electron beam generally scans the surface of the sample in a raster scan 
pattern, and then combines the position and detected signal to create an image of the 
surface topography of the sample. Typically, the detected signal of the SEM system 
can be either secondary electrons (SE) or back-scattered electrons (BSE), with 
secondary electron detectors being the most common. These signals result from the 
focused electron beam interacting with atoms at various depths within the sample 
(depending on the substrate material and the voltage parameters of the SEM system), 
with the signal generated depending on the penetration depth. Very close to the 
surface, the beam of electrons interacts with the sample inelastically and results in 
ionisation of the sample. Secondary electrons (SE) are then emitted, which have an 
energy much lower than the primary electron beam, and can normally produce high-
resolution images of sample surfaces with details of around 1 nm. In comparison, 
back-scattered electrons (BSE) are produced by elastic scattering from the sample 
and emerge from a larger depth from the surface. As these back-scattered electrons 
are generated from deeper locations within the sample, the resolution of the images 
are generally worse than images created from secondary electrons. 
One important point to note for SEM images, especially when measured in secondary 
electron mode, is that non-conductive samples become charged when scanned with 
the primary electron beam, and this can cause scanning faults and artefacts on the 
SEM image. To prevent this accumulation of electrostatic charge, samples must be 
electrically conductive (at least on the surface), and so non-conductive materials are 
typically coated with a conductive material such as gold or platinum. 
The structures used throughout this thesis were initially characterised using two 
different SEM microscopes; an FEI Nova NanoSEM 630, and a Hitachi S4700 SEM. 
All images were recorded through the secondary electron method described above. 
The resolution limit of the FEI Nova NanoSEM 630 is ~5 nm at 10 keV, and the Hitachi 
S4700 SEM has a resolution limit of ~10 nm at 10 keV. The Hitachi S4700 SEM 
microscope, with the lower resolution limit, was initially used to quickly monitor the 
quality of the fabrication process throughout, with the FEI Nova NanoSEM 630 used 
to obtain high quality images for the characterisation of the final substrates.  
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Figure 3.06 SEM image of right handed shuriken structures recorded using the FEI Nova 
NanoSEM 630, after the evaporation of 100 nm gold onto the nanostructured surface. 
 
3.3.2 Atomic Force Microscopy (AFM) 
Atomic force microscopy is a type of scanning probe microscopy that uses a 
mechanical probe to gather information from a samples surface, and has a resolution 
on the order of sub-nanometres. 
 
Figure 3.07 Graphical description of atomic force microscopy (AFM) system. 
 
The atomic force microscope consists of a cantilever with a sharp tip at its end, known 
as the probe, which typically has a radius at its end on the order of a few nanometres 
to tens of nanometres. There are two main modes in which the microscope can be 
operated; either in static mode, where the tip is in contact with the sample surface, or 
37 
 
dynamic mode, where the cantilever is oscillated at a given frequency along the 
sample surface. In static or contact mode, the AFM tip is essentially dragged along 
the surface of the sample measuring the contours of the surface directly. Whereas, in 
dynamic or tapping mode, the tip is brought into close proximity of the sample surface, 
and oscillates at its resonant frequency. As the tip is in close proximity to the surface, 
this allows short range forces to act upon the tip, such as Van der Waals forces, 
dipole-dipole interactions, and electrostatic forces, causing the frequency of the 
cantilevers oscillation to change. This amplitude change alerts the system to alter the 
height of the cantilever till the initial oscillation amplitude is restored. This is 
continually adjusted as the tip scans the sample surface, and the height change 
modulates the reflection of the laser off the top of the cantilever. This change in 
reflection is then detected by the photodiode (Figure 3.07), and allows an accurate 
topological image of a surface to be achieved. The thickness of the AFM tip often 
dictates the resolution achieved by the system, as a thinner tip will be more accurate 
and will be able to decipher the smaller features of the sample surface with more 
accuracy. 
The AFM data collected when characterising the nanostructure substrates used 
throughout this thesis were collected using a Bruker Dimension Icon Atomic Force 
Microscope. The data were collected in tapping mode, with the vertical noise of the 
system being < 30 pm. 
 
Figure 3.08 AFM image, and height profiles, for shuriken structures covered with 100 nm gold. 
Red and blue lines overlaying the AFM image correspond to the regions where the similarly 
coloured height profiles were measured. 
 
The AFM images and height profiles, Figure 3.08, show that the depth of the shuriken 
structures after deposition of 100 nm gold is ~70 – 80 nm. It can also be observed 
that the height profile does not sharply drop off to a minimum, but gradually decreases 
over a small distance. This shows that the vertical walls of the indentations slope 
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gradually to the base of the structure, resulting in a continuous gold film, as the side 
walls are completely coated with gold. 
 
3.4 Spectroscopy 
3.4.1 Polarisation Microscope 
All linear spectroscopic measurements throughout this thesis were recorded using a 
custom built polarisation microscope, as shown in Figures 3.09 and 3.10. A 50W 
tungsten halogen lamp (Thorlabs) serves as an unpolarised broadband light source, 
with the light passing through a collimating lens, and then a Glan-Thompson calcite 
polariser (Thorlabs), to generate a vertically polarised beam of light. This polarised 
beam of light then passes through a 50:50 beamsplitter, with the diverted beam 
passing through a 10x objective lens with 0.3 numerical aperture (Olympus UPlanFLN 
10x). The light is then reflected from the sample and passes back through the 
beamsplitter, and then through a further Glan-Thompson polariser (Thorlabs) before 
passing through a second 50:50 beamsplitter. One output from the second 
beamsplitter is sent to a camera (Thorlabs CMOS Camera, DCC1645C), to image the 
surface and assist in aligning the microscope, with the second output being collected 
by the spectrometer (Ocean Optics USB4000).  
 
Figure 3.09 Schematic representation of the custom built polarisation microscope. 
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Figure 3.10 Photograph detailing the custom built polarisation microscope. 
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The Thorlabs camera (DCC1645C) is used to assist in the positioning and focus of 
the nanostructure array. The camera is positioned after the second beamsplitter and 
gives a clear image of the reflected beam off the surface, with an approximate field of 
view of 350 x 350 μm, Figure 3.11. 
 
Figure 3.11 Picture from Thorlabs DCC1645C camera showing field of view for custom built 
polarisation microscope. 
 
The image in the camera allows the sample to be consistently positioned in the same 
place for each measurement. The sample position can then be fine-tuned by adjusting 
the rotation and tilt stage, so that the reflected beam is normal to the sample surface. 
 
3.4.2 Optical Rotatory Dispersion Spectroscopy 
Optical rotatory dispersion (ORD) spectra can be measured for both the left- and right-
handed plasmonic structures. Using Stokes parameters, the ORD spectra can be 
calculated by measuring the light intensity at four different polarisation angles relative 
to the incident polarisation. The measurements are recorded at 0o, 45o, 90o and 135o 
(equivalent to -45o), and the ORD calculated as: 
𝑂𝑅𝐷 =  
1
2
tan−1
(𝐼45 −  𝐼135)
(𝐼0 −  𝐼90)
 
To reduce background noise, measurements are collected from both left-handed and 
right-handed structures, as well as the flat gold surface, and repeated for four sets of 
measurements. The ORD measured from the flat gold background is then subtracted 
(3.4.1) 
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from the left- and right-handed nanostructure spectra. For each handedness of the 
chiral nanostructures, left- and right-handed shurikens, the ORD spectra will be equal 
and opposite, resulting in a bisignate shape shown in Figure 3.12. The ORD spectra 
arises due to a plasmonic excitation, with the wavelength of these plasmonic 
resonances depending on the refractive index of the surrounding medium. So, when 
the refractive index above the chiral nanostructures increases, the wavelength 
position of the plasmonic resonance would experience a red shift.  
 
Figure 3.12 Example ORD spectra measured from left- (red) and right-handed (blue) 
nanostructures with water (solid) and a higher refractive index solution (dashed) on the 
substrate surface. 
 
To characterise the asymmetry in the wavelength position, between left- and right-
handed nanostructures, ORD spectra for both handedness of nanostructures are 
recorded for water/buffer as a reference. The higher refractive index solution, or 
protein solution, is then adsorbed onto the substrate surface, and the ORD spectra 
measured the same way as before. Each measurement, buffer and analyte, are 
repeated four times and averaged to further reduce the noise and error in the system. 
The peak positions of these ORD spectra are then measured, and the change in 
wavelength is calculated for both left- and right-handed structures as follows: 
∆𝜆𝑅𝐻/𝐿𝐻 =  𝜆(𝐴𝑛𝑎𝑙𝑦𝑡𝑒) −  𝜆(𝐵𝑢𝑓𝑓𝑒𝑟) (3.4.2) 
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This gives the ∆𝜆𝑅𝐻/𝐿𝐻 wavelength shift parameter for both the left- and right-handed 
nanostructures, as shown in Figure 3.12. An asymmetry parameter, ∆∆𝜆, can then be 
defined from the wavelength shift of each handedness of nanostructure, ∆𝜆𝑅𝐻 and 
∆𝜆𝐿𝐻, and can be measured as: 
∆∆𝜆 =  ∆𝜆𝑅𝐻 −  ∆𝜆𝐿𝐻 
For achiral media, such as salt solutions, the solution is completely isotropic, and 
would have the same contribution to both left- and right-handed chiral fields. This 
results in the wavelength shift of the resonance for left- and right-handed 
nanostructures being equal, giving a zero ∆∆𝜆 value. Contrary to achiral solutions, 
when a solution containing chiral molecules (such as protein solutions) is placed 
above the substrate surface, the wavelength of the plasmonic resonance shifts 
asymmetrically for the left- and right-handed nanostructures. Resulting in a 
measurable change of the ∆∆𝜆 value. This occurs as the adsorbed species are no 
longer isotropic, and therefore would interact asymmetrically with the chiral fields of 
opposing handedness. 
The asymmetry parameter, ∆∆𝜆, will be used in chapter 4 to quantify higher order 
structural changes in two well characterised proteins, which undergo ligand induced 
conformational changes. 
 
3.4.3 Reflectance Spectroscopy 
In addition to the optical rotatory dispersion spectra, reflectance spectra can also be 
obtained from the chiral gold nanostructures. However, instead of measuring the light 
intensity with the output polariser at 4 different angles, all of the reflectance 
measurements are measured with the analyser at 0o. The reflected light intensity is 
measured from the nanostructures, both left- and right-handed, and then 
measurements are taken from the flat gold. These measurements are taken with 
buffer, as reference, and then with the desired solution on the surface of the substrate. 
All these measurements are repeated 8 times, and then averaged to reduce the noise 
and error within the system. Reflectance spectra can then be calculated as: 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑅𝑒𝑓𝑙𝑒𝑐𝑡𝑎𝑛𝑐𝑒 =  (
𝐼𝑁𝑎𝑛𝑜𝑠𝑡𝑟𝑢𝑐𝑡𝑢𝑟𝑒
𝐼𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝐺𝑜𝑙𝑑
) 
(3.4.3) 
(3.4.4) 
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Contrary to the opposite ORD spectra we see from the chiral nanostructures, the 
reflectance spectra generated by both left- and right-handed shurikens show a near 
identical shape to each other, Figure 3.13.  
 
Figure 3.13 Example reflectance spectra for both left- and right-handed shuriken structures 
with water (black), and a higher refractive index solution (coloured) on the substrate surface. 
 
The main resonance in the reflectance spectra, shown in Figure 3.13, shows a peak 
of reflectivity occurring within a significant reflectance dip. This occurs, as described 
in Chapter 2, as a result of the plasmonic analogue of electromagnetically induced 
transparency. Where strong coupling occurs between the optically bright dipolar and 
the optically dark quadrupolar modes of the nanostructures [4]. 
From the reflectance spectra, a new asymmetry parameter can be introduced. Instead 
of measuring the wavelength shift of the resonance, which was measured for the ORD 
results, the separation between the two reflectance dips can be measured for differing 
solutions (Figure 3.13). This value is quantified in a similar fashion to ∆∆𝜆, where the 
∆𝑆𝑅𝐻/𝐿𝐻 value must first be calculated using: 
∆𝑆𝑅𝐻/𝐿𝐻 = 𝑆
𝑅𝐻/𝐿𝐻
(𝐴𝑛𝑎𝑙𝑦𝑡𝑒) −  𝑆
𝑅𝐻/𝐿𝐻
(𝐵𝑢𝑓𝑓𝑒𝑟) 
This ∆𝑆𝑅𝐻/𝐿𝐻 value, can be measured for both the left- and right-handed 
nanostructures, as shown in Figure 3.13, to give a ∆𝑆 value for each handedness. 
Therefore, to obtain the final asymmetry parameter for the reflectance data, the ∆∆𝑆 
value can be calculated using: 
∆∆𝑆 =  ∆𝑆𝑅𝐻 − ∆𝑆𝐿𝐻 
(3.4.5) 
(3.4.6) 
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The separation asymmetry parameter, ∆∆𝑆, can be used to characterise and identify 
changes that are seen in the reflectance spectra due to changes in the solutions or 
proteins absorbed to the substrate surface. In agreement with the ORD 
measurements, there should be no separation asymmetry in the reflectance spectra 
when achiral solutions of a higher refractive index are added to the substrate. 
However, when a solution of chiral molecules, or protein solution, is adsorbed on the 
substrate surface, the effect on the left- and right-handed spectra will be unequal, 
creating an asymmetrical change, which can be measured by the ∆∆𝑆 parameter. 
This change in the ∆∆𝑆 parameter will be used in chapters 5, 6 and 7 to quantify 
protein conformational changes, variations in surface immobilised orientation, and 
concentration differences of Immunoglobulin G within spiked human blood serum 
solutions. 
 
3.4.4 Electromagnetic Modelling 
To determine the spatial distribution, and level of chiral asymmetries, in the fields 
generated by the shuriken nanostructures, electromagnetic (EM) simulations for 
linearly polarised light with wavelength in the resonance region of 700 nm were 
performed using COMSOL Multiphysics software. The chiral asymmetries of the 
evanescent fields generated by the chiral shuriken structures was characterised using 
the optical chirality parameter first proposed by Tang and Cohen [5], and is described 
in chapter 2. 
 
Figure 3.14 EM simulation of chiral field plots for (a) top surface, and (b) bottom surface of 
the shuriken structure. The black arrow represents the direction of incident polarisation. 
 
45 
 
From the results shown in Figure 3.14, when the structure was excited with linearly 
polarised light, chiral evanescent fields of both left- and right-handed chiral 
asymmetries are generated, with one handedness generated in excess. The chiral 
fields are largest at the top surface of the nanostructure, with the bottom surface 
showing chirality values almost an order of magnitude smaller. From Figure 3.14(a) 
and (b), it looks as though the magnitude of the chiral fields produced with opposite 
handedness (blue and red) would cancel each other out at the surface. However, 
when the chirality values are integrated over the respective surface, an integrated 
optical chirality value is achieved. With these values being -930 and 168, for the top 
and bottom surfaces respectively, indicating that there is a large chiral asymmetry 
value overall. This reinforces the fact that the shuriken shaped nanostructures 
generate evanescent fields with enhanced chiral asymmetries relative to circularly 
polarised light, with the overall asymmetry being governed by the handedness of the 
structure [6, 7]. 
 
3.4.5 Refractive Index Measurements 
To initially characterise the sensitivity of the chiral shuriken nanostructures, 
calibration measurements using solutions of achiral media of increasing refractive 
index were performed. Solutions of NaCl of differing concentrations, as well as 
ethanol, were used to give different refractive index solutions, without changing the 
chirality on the surface of the substrate. The calibration solutions consisted of water, 
1 M NaCl solution, 2.2 M NaCl solution, ethanol, and 4.4 M NaCl solution, with the 
measured refractive index of each solution being 1.334, 1.343, 1.353, 1.361, and 
1.370 respectively. ORD measurements were recorded in the presence of each 
solution on the nanostructure surface, starting with water and increasing the refractive 
index to the final solution of 4.4 M NaCl solution. Figure 3.15 shows the ORD spectra 
for both left- and right-handed structures for all refractive index salt solutions, and 
graphs showing the peak positions for each solution, and asymmetry parameter 
between each solution and water. In Figure 3.15(c), blue and red lines are also 
included to show the asymmetry parameter values produced from two exemplar 
proteins, that will be studied in chapter 4, relative to the salt solution values. The 
reflectance measurements were characterised in the same way as the ORD spectra, 
described above. Calibration solutions consisting of water and salt solutions were 
produced with refractive indices of 1.333, 1.337, 1.340, and 1.344. With the 
reflectance spectra for each refractive index being shown in Figure 3.16(a). 
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Figure 3.15 (a) ORD spectra for left- and right-handed nanostructures in the presence of 
achiral salt solutions of increasing refractive index, (b) peak positions for left- (red) and right-
handed (blue) shuriken structures with increasing refractive index solutions, and (c) 
asymmetry values relative to water for increasing refractive index, with comparison of 
asymmetry values for two exemplar proteins, EPSP Synthase and SK (Chapter 4). The error 
bars represent the standard error calculated from 8 spectra measurements. 
 
Figure 3.16 (a) Reflectance spectra for left- and right-handed nanostructures in the presence 
of achiral salt solutions of increasing refractive index, (b) average positions for left- (red) and 
right-handed (blue) shuriken structures with increasing refractive index solutions, and (c) 
asymmetry values relative to water for increasing refractive index. The error bars represent 
the standard error calculated from 8 spectra measurements.  
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From Figures 3.15(a) and 3.16(a), it can be seen that by adding the achiral salt 
solutions of increasing refractive index, the plasmonic resonance in the ORD spectra 
and the positions of the reflectance spectra experience a red shift in their wavelength. 
When we look at the wavelength shifts for the left- and right-handed shuriken 
structures, for both ORD and reflectance, the shift is linear for both structures with the 
magnitude of the shift being equal between left- and right-handed structures, shown 
in Figures 3.15(b) and 3.16(b). As expected for achiral media, like salt solutions, there 
is no asymmetry difference within experimental error for the increasing refractive 
index relative to the initial water measurements. These results are shown for the ORD 
and reflectance measurements in Figures 3.15(c) and 3.16(c) respectively. This is 
due to the right- and left-handed chiral fields interacting equally with the achiral media, 
and hence producing no net chiral asymmetry, as described previously.  
 
3.5 Surface Functionalisation and Preparation 
3.5.1 Nitrilotriacetic Acid (NTA) Functionalisation 
To functionalise the gold substrate surface, a thiolated nitrilotriacetic acid (NTA) 
monolayer was co-adsorbed with triethylene glycol mono-11-mercaptoundecyl (EG-
thiol), using a process previously described in the literature by Sigal et al. [8]. Firstly, 
the gold substrates are cleaned in an oxygen plasma cleaner for 20 seconds at 160W 
before being immersed in a 95% ethanol solution and bubbled with nitrogen. A further 
solution, in 95% ethanol, is made containing 0.1 mM NTA (Prochimia Surfaces) and 
0.9 mM EG-thiol (Sigma Aldrich) giving a total thiol concentration of 1 mM. The clean 
gold substrates are then placed into the thiol solution and bubbled with nitrogen gas 
for a further 5 minutes. After bubbling with nitrogen, the substrates are left in the thiol 
solution to incubate overnight (16-20 hours), which allows for the formation of a self-
assembled monolayer (SAM) on the substrate surface.  The samples are removed 
from the thiol solution before being rinsed with 95% ethanol, and then incubated in 1 
mM sodium hydroxide for 5 minutes. They are then rinsed with water, and left to 
incubate for 1 hour in a 40 mM nickel (II) sulphate solution. Finally, the samples are 
removed and rinsed with ~1 ml HBS (HEPES buffered saline, 10 mM HEPES and 
150 mM NaCl in water at pH 7.2), and then ~5 ml of water before being dried under 
a stream of nitrogen. 
When the nickel (II) sulphate solution is added to the self-assembled monolayer, the 
Ni2+ adsorbs to the surface NTA groups to create an NTA/Ni2+ complex.  
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Figure 3.17 Scheme showing NTA monolayer functionalisation, binding of Ni2+, and final 
binding of His-tagged protein to the NTA/Ni2+ complex. 
 
The NTA/Ni2+ chelate formed on the surface, has a high affinity for specifically binding 
His-tagged proteins, through the binding of the two vacant sites on the Ni2+ ions and 
the histidine group attached to the protein. This allows the proteins to be attached to 
the surface of the gold substrate with a consistent and uniform orientation over the 
whole area. Binding proteins to the gold surface using this method has previously 
been shown to have very little effect on the bound proteins ability to interact with other 
proteins or ligands in solution [9, 10]. 
In chapters 4 and 6, the gold substrates were functionalised, as described above, with 
a mixed monolayer of NTA and EG-thiol. However, in chapter 7, the gold substrates 
were functionalised with a monolayer consisting of NTA only, and no nickel (II) 
sulphate solution was added. This resulted in a completely charged monolayer, 
consisting of NTA, and possessing a negative charge across the whole surface, 
suitable for preferentially binding the net positively charged immunoglobulin G 
protein. 
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3.5.2 Protein Preparation 
The preparation of the His-tagged proteins were all done, by the Lapthorn lab at the 
university of Glasgow, following the same method described here, unless otherwise 
stated. 
Existing genes of the protein, cloned into a pET 22b vector are transformed and over 
expressed in BL21 star cells. Liquid Luria Broth (1 litre) is used to grow the cells, and 
protein expression is induced with isopropyl β-D-1-thiogalactopyranoside (IPTG) at 
an optical density of 0.6 at 600 nm. The cells are harvested 3 hours after induction by 
centrifugation and re-suspended in 50 mM Tris/HCl buffer at pH 7.8, before being 
lysed using sonication and centrifuged at 2000 rpm to remove all insoluble matter. 
The protein is then purified from the cell lysate by NTA nickel chromatography, with 
the protein being eluded using 300 mM imidazole, 300 mM NaCl in 100 mM Tris/HCl 
buffer at pH 7.8. Next, the protein is concentrated by centrifugal concentration and 
buffer exchanged by dialysis in 50 mM Tris/HCl buffer pH 7.5. The purity of the protein 
is then assessed by SDS-Page gel electrophoresis and the enzyme activity checked 
using a phosphate release assay. 
 
3.5.3 Microfluidic Chamber 
To perform the spectroscopic measurements on the gold substrates, in the presence 
of buffer or other solutions, the substrate needs to be inserted into a custom made 
microfluidic cell. This microfluidic cell was custom designed and 3D printed to produce 
a chamber that had the perfect size to accommodate the TPS, and allow a chamber 
with an approximate volume of 300 μl. 
 
Figure 3.18 Labelled photo, showing top and side view, of custom made 3D printed 
microfluidic chamber for TPSs. 
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The watertight microfluidic chamber is made by placing the clean TPS at the base of 
the 3D printed structure, then a silicon layer with a hole cut in the middle is added to 
expose the chiral nanostructures on the TPS. A clean glass microscope slide is 
placed on top of this, and the plastic top layer inserted to apply pressure to the system, 
and create the watertight seal between the glass slide and TPS using the silicon layer. 
Two hypodermic needles are inserted at opposing sides, that allow for insertion and 
extraction of any solutions added, to complete the assembly of the microfluidic 
chamber. 
 
3.6 Modelling 
3.6.1 Mathematical Model for EIT 
The basis of the model used to fit plasmonic induced transparency spectra within this 
thesis was first proposed by Zhang et al. [4], and subsequently used by Tassin et al. 
[11]. This classical model, used to describe plasmonic induced transparency, is based 
on two coupled oscillators, and is described in chapter 2. To generate the fitting 
spectra, and change the data to accurately fit the experimental results, a script was 
created in MATLAB (Mathworks R2016b) to implement the coupled oscillator 
equations. To accurately fit the data, ten parameters were initially changed to achieve 
the best fit possible for all water/buffer reference measurements. The ten parameters 
and their definitions are shown in Table 3.01. 
 
Table 3.01 Descriptions of the parameters that are used to implement the mathematical model 
for plasmonic induced transparency. 
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Figure 3.19 Effect of varying each parameter in the model by small increments from the initial 
values. 
 
Figure 3.19 shows the results of varying each parameter by a small amount, relative 
to the initial values for each parameter, and how these small changes affect the size 
and shape of the reflectance spectra formed. By varying all these parameters, we can 
tune the fitting spectra for the buffer to be relatively similar. However, when fitting the 
protein or solution data, added after taking the water/buffer measurements, only five 
of the parameters are changed from the initial water/buffer fit; 𝜔𝑟, 𝜔𝑑, 𝑘, 𝜃, and 𝜙. 
From these five parameters, 𝜔𝑟 and 𝜔𝑑 shift the bright and dark modes respectively, 
𝑘 controls the coupling strength and affects the separation between the two 
reflectance dips, and 𝜃 and 𝜙 vary the heights of the reflectance dips as shown in 
Figure 3.19, with 𝜃 also slightly tilting the whole spectra. 
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3.6.2 Salt Solution Modelling 
To test the model sensitivity and accuracy at modelling the experimental reflectance 
data, the salt solutions shown in Figure 3.16 were modelled. All ten parameters were 
initially allowed to vary to fit the water data, with the five listed parameters varying to 
fit the subsequent salt solution spectra. The values for each parameter used to fit the 
salt solution data are shown in Table 3.02, with the values of each of the five variable 
parameters plotted against refractive index in Figure 3.20. 
 
Table 3.02 Parameter values used to fit the experimental salt solution spectra for left- and 
right-handed shuriken structures. 
 
Figure 3.20 (a) Experimental reflectance spectra (black) and fitting of data without the 
consideration of phase (blue dashed), and with the introduction of phase (red), and (b-d) fitting 
results for 𝜔𝑟, 𝜔𝑑, 𝑘, 𝜃, and 𝜙 compared to the refractive index of solutions. The error bars 
represent the standard error calculated from 8 spectra measurements. 
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Figure 3.20(a) shows optimised modelled spectra for the reflectance spectra of water, 
from the shuriken structures, when phase is ignored (blue dashed), and when the 
phase is considered in the fitting parameters (red). From this figure, it is important to 
note that the reflectance spectra, recorded for the shuriken structures here, cannot 
be well replicated using the coupled oscillator model previously used [4, 11], but 
requires any retardation phase shifts to be considered (Figure 3.20(a)). The 
requirement of including phase in the fitting model, is a result of retardation effects 
becoming significant due to the size of the nanostructures now being comparable to 
the wavelength of light, which is different to EIT in atomic systems. In previous 
studies, where plasmonic induced transparency has been modelled using the coupled 
oscillator model without the introduction of phase shifts, the nanostructures used have 
been of a much smaller size and therefore retardation effects would have been much 
less significant [4]. In Figure 3.20(b-d), the values 𝜔𝑟, 𝜔𝑑, 𝑘, 𝜃, and 𝜙 for the fitted 
spectra were plotted against the refractive index of the solutions. As is expected for 
achiral solutions, both 𝜔𝑟 and 𝜔𝑑 exhibit a wavelength shift that increases linearly as 
a function of the refractive index for both left- and right-handed nanostructures. All 
four values, radiative and dark resonances for both handedness of structures, show 
the same refractive index sensitivity, within the precision of our measurements, of 
~400 nm/RIU. All three of the other variable parameters, 𝑘, 𝜃, and 𝜙, all show no 
changes within the error of our measurements, meaning there are no refractive index 
dependencies on the coupling or phase parameters for achiral media. 
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Chapter 4: Detection of Ligand Induced Changes in 
Protein Higher Order Structure 
4.1 Introduction 
Traditionally, X-ray crystallography [1], and nuclear magnetic resonance (NMR) [2] 
are the two common techniques that are routinely employed to determine and 
characterise the higher order structure of proteins. These techniques however, 
require a lot of material, and are very time consuming, with NMR failing when larger 
proteins are being elucidated. As a result of these limitations, X-ray crystallography 
and NMR are unsuitable for the high throughput characterisation of proteins required 
for many analytical applications. 
Optical spectroscopic techniques typically do not provide a spectral fingerprint of the 
higher order structure of proteins, such as the tertiary or quaternary structural 
changes seen for many protein-ligand interactions. In this chapter, we will 
demonstrate that the optical response of the chiral plasmonic nanostructures are 
sensitive to the higher order structural changes observed in many proteins. The 
phenomenon introduced here, ‘superchiral’ polarimetry, is a label-free and chirally 
sensitive spectroscopic technique. Which will be shown to be sensitive to ligand 
induced changes in the higher order structures of two well characterised proteins, that 
are not detected when using conventional methods, such as circular dichroism. This 
increased sensitivity arises from the smaller mismatch between the effective helical 
pitch of the superchiral fields and the length scale of the protein structures, when 
compared with circularly polarised light. This is demonstrated using two proteins from 
the Shikimate pathway, EPSP Synthase and Shikimate Kinase, which both undergo 
well defined ligand induced structural changes. Each protein differs in size, ligand 
affinity, and the nature of the ligand induced conformational change, making them the 
ideal test for exhibiting this new approach.  
The phenomenon, ‘superchiral’ polarimetry, relies upon measuring optical rotatory 
dispersion (ORD) spectra, and characterising the changes in these spectra using the 
asymmetry parameter, ∆∆𝜆, described in Chapter 3. This is a rather simplistic 
interpretation of the data measured from the chiral shuriken structures, and further 
protein binding characteristics will be examined in chapters 5, 6, and 7 using a more 
detailed interpretation of the reflectance spectra recorded from each nanostructure.  
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4.2 Proteins 
4.2.1 The Shikimate Pathway 
The shikimate pathway is a seven step metabolic process, found only in 
microorganisms and plants, that leads to the production of aromatic amino acids. 
Since the pathway is not found in animals, interrupting this pathway is an important 
target for many herbicides, such as glyphosate [3]. Two of the enzymes from the 
shikimate pathway, 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase from 
Escherichia coli and shikimate kinase (SK) from Erwinia chrysanthemi, were chosen 
for this study, as they both undergo ligand induced conformational changes but differ 
in size, ligand affinity, and the nature of the conformational changes.  
 
4.2.2 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase  
The enzyme 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase is the sixth 
enzyme in the shikimate pathway, and catalyses the reaction between shikimate-3-
phosphate (S3P) and phosphoenolpyruvate (PEP) to form 5-enolpyruvylshikimate-3-
phosphate (EPSP). It is a 46 kDa molecular weight protein, that folds into two similar 
domains, as seen in Figure 4.01(a). 
 
Figure 4.01 Ribbon representations of the crystal structure of EPSP Synthase (a) open form 
of protein (PDB 2BJB), and (b) closed form of protein after binding (PDB 2O0E) of glyphosate 
and shikimate-3-phosphate ligand. 
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Protein crystallography data has been extensively studied for EPSP Synthase, which 
provides high resolution structures for both the open form and ligand bound form of 
the specific protein, or closely related species [4, 5]. The crystal structures, and ribbon 
representations shown in Figure 4.01, show that EPSP Synthase exists as a 
monomer that is comprised of two similar domains connected by a flexible strand. 
Upon ligand binding, the ligand interacts with both domains of the protein bringing 
them closer together in a screw-like movement, with the active site being in the 
interdomain cleft, Figure 4.01(b) [6]. As a result of this ‘hinge’ closure, a more compact 
structure and rigid alignment of the α- helices and β-sheets is produced. The ligands 
that bind to EPSP Synthase to irreversibly induce this conformational change are; 
shikimate-3-phosphate (S3P), and the inhibitor glyphosate. Glyphosate acts as the 
primary inhibitor of EPSP Synthase and is the active ingredient found in most 
commercially available herbicides. Both these ligands, S3P and glyphosate, bind to 
EPSP Synthase with low micromolar affinities [7].  
 
4.2.3 Shikimate Kinase (SK) 
Shikimate kinase (SK) is the fifth enzyme in the shikimate pathway, and is responsible 
for catalysing the ATP dependent phosphorylation of the 3-hydroxyl group of shikimic 
acid, to form shikimate-3-phosphate. The structure of shikimate kinase is very 
different compared with EPSP Synthase, as it is a much smaller protein at 19 kDa, 
and is a single domain structure, as shown in Figure 4.02.  
 
Figure 4.02 Ribbon representations of the crystal structure of SK (a) open form of protein 
(PDB 2IYV), and (b) closed form of protein after binding (2IYQ) of ADP, shikimic acid and 
MgCl2. 
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Protein crystallography data, as well as molecular modelling, has been used to 
provide detailed structures for the open, and closed ligand bound structures of 
shikimate kinase [8, 9]. The SK enzyme is an α/β protein that is composed of two 
major domains; the lid domain, and the shikimate binding (SB) domain. Upon ligand 
binding, a hinged movement of the lid domain and shikimate binding domain occurs, 
bringing them closer to each other, and towards the active centre of the protein [10]. 
This results in the small lid domain ‘closing’ over the active site on ADP binding, and 
the helix-loop-helix of the SB domain becoming more ordered, as shown in Figure 
4.02(b). This conformational change is induced by ligand solutions containing ADP, 
shikimic acid, and MgCl2, with the protein binding these ligands with high micromolar 
to low millimolar affinities [11]. 
 
4.3 Results and Discussion 
4.3.1 Immobilisation Coverage 
As the two proteins used throughout this study undergo significant structural changes 
upon ligand binding, the surface coverage of the protein becomes an important 
parameter. To control the surface coverage of the proteins, self-assembled 
monolayers of increasing NTA concentrations were immobilised onto the 
nanostructure surface, and EPSP synthase added. Figure 4.03 shows the correlation 
between the overall coverage of EPSP synthase, and the asymmetry value produced. 
 
Figure 4.03 Asymmetry values against corresponding surface coverage for increasing 
coverage of EPSP synthase immobilised onto the shuriken nanostructures. The error bars 
represent the standard error calculated from 8 spectra measurements. 
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Figure 4.03 shows that as the coverage of EPSP Synthase on the surface of the 
nanostructures increases, as measured by the average shift from the left- and right-
handed structures, there is a linear increase in the asymmetry value observed. Even 
though a greater surface coverage of the protein produces a much larger asymmetry, 
it is not always beneficial to have such a high coverage. The middle coverage shown 
in Figure 4.03, is the NTA concentration used throughout this chapter, with an 
NTA/EG-thiol concentration of 0.1 mM/0.9 mM, respectively. This coverage was 
chosen throughout as it gives a significant asymmetry response for the proteins with 
the chiral shuriken structures, but also creates large enough spacing between the 
immobilised proteins to allow unhindered structural changes upon binding of the 
respective ligands. 
 
4.3.2 Measurement of Protein Structural Changes 
The proteins, EPSP Synthase and shikimate kinase, were both recombinant histidine 
tagged (His-tagged) proteins that were immobilised on the gold substrate surface 
using an established methodology [12], described in chapter 3. This allows the 
proteins to be adsorbed to the surface in a well-defined fashion, as the His-tag is 
positioned on the N-terminus of the proteins, giving a consistent relative binding 
orientation across the whole substrate. As a result of the defined binding orientation 
of the protein to the surface, and the spacing of the protein binding sites created by 
the NTA/EG-thiol monolayer, the conformational changes in the structure can occur 
unhindered upon ligand binding to the protein. ORD measurements were taken for 
both handedness of shuriken structures, after the formation of the NTA/EG-thiol SAM 
on the substrate surface, in the presence of buffer, and used as the initial reference 
spectra. This was repeated after the adsorption of the proteins, and after the 
introduction of the ligand solutions to the adsorbed proteins. The spectra for each 
measurement was then plotted for buffer alone, immobilised protein in buffer, and 
immobilised protein in the presence of ligand solution, Figure 4.04. The ORD spectra 
for ligand only solutions, and the average shifts for each stage of the protein 
measurements (protein immobilisation, ligand binding to adsorbed proteins, and 
ligand only solutions), are included in Appendix C. The average shifts for the 
structures can be thought of as being analogous to surface plasmon resonance 
measurements, and were calculated as ∆𝜆𝐴𝑣𝑔 =  (∆𝜆𝑅 +  ∆𝜆𝐿) 2⁄ , where ∆𝜆𝑅 and ∆𝜆𝐿 
are the shifts for the right- and left-handed nanostructures respectively.    
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Figure 4.04 ORD data for (a) EPSP Synthase, and (b) shikimate kinase. The top graph of 
each show the spectra in the presence of buffer only (solid line) to immobilised protein in the 
presence of buffer (dotted lines), and the bottom graph of each shows the spectra for 
immobilised protein (from top graph) and immobilised protein in the presence of ligand 
solutions (dash-dot line). (c) shows ∆∆𝜆 values calculated from the ORD spectra for 
immobilised protein, protein in the presence of ligand solution, and ligand solution only. The 
error bars represent the standard error calculated from 8 spectra measurements. 
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Figure 4.04 shows the spectra for both proteins, EPSP Synthase and shikimate 
kinase, after immobilisation of the protein relative to the initial buffer measurements, 
and after addition of the ligand solutions to the immobilised proteins, relative to the 
previous immobilised protein only measurements. The ligand solutions also contain 
chiral molecules, with shikimic acid, ADP, and shikimate-3-phosphate all containing 
chiral centres. As a control on the effect of the chirality of the ligand solutions, ORD 
measurements were recorded in the presence of each respective ligand solution, in 
the absence of any adsorbed protein. The asymmetry parameter values, ∆∆𝜆 
introduced in chapter 3, for the immobilised protein, immobilised protein in the 
presence of ligand solution, and ligand solution only in the absence of protein are also 
included in Figure 4.04(c), showing no asymmetry for either solution within 
experimental error. The asymmetry parameter for the immobilised protein is 
calculated relative to the initial buffer measurement, and relative to the immobilised 
protein position for the protein and ligand solution measurements.  
Upon immobilising the proteins on the substrate surface, both EPSP Synthase and 
shikimate kinase produced positive asymmetry values significantly larger than the 
values seen for the ligand solutions alone. When the ligand solutions were added to 
the respective adsorbed proteins, the conformational changes induced for each 
protein both produce a large negative ∆∆𝜆 response, relative to the initial 
immobilisation value. With EPSP synthase showing the largest asymmetry upon 
ligand binding, as seen in Figure 4.04. 
 
4.3.3 Circular Dichroism Spectroscopy 
As a comparison to conventional spectroscopy, UV-Vis circular dichroism (CD) 
spectra were also recorded for both protein systems. The CD spectra were collected 
for both proteins on their own, as well as with the relative ligand solutions present, 
meaning spectra could be obtained for the proteins in their unliganded (open) and 
ligand bound (closed) states. The spectra were also collected for both the far and 
near UV regions, which are sensitive to the secondary and tertiary protein structure 
respectively. The UV-Vis CD spectra for both proteins in the near and far UV regions, 
for both open and closed ligand bound structures are shown in Figure 4.05. 
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Figure 4.05 CD spectra for unliganded (blue) and ligand bound (red) protein, for EPSP 
Synthase and shikimate kinase in the top and bottom panels respectively. Spectra are shown 
for both the far UV and near UV spectra, in the left and right panels respectively. 
 
In CD spectroscopy, the far UV and near UV regions are sensitive to the secondary 
and tertiary structure of the proteins respectively, with the tertiary sensitivity of near 
UV arising from changes in the surrounding environments of the aromatic amino acids 
present within the structure. [13]. In the CD spectra for EPSP Synthase, it can be 
seen that there are no changes in either the far UV or near UV spectra when the 
protein goes from its unliganded open form, to its closed ligand bound form. Indicating 
that in the case of EPSP Synthase, CD spectroscopy is insensitive to the large 
changes in the quaternary structure that occur upon the ligand induced 
conformational change. In the case of shikimate kinase, the near UV spectra is 
uninformative as it overlaps a region where the unbound ligand solution absorbs light, 
limiting the collection of good quality data in this region. In the far UV region, a small 
change can be seen upon ligand binding for shikimate kinase, with no significant 
change seen in the near UV spectra for the limited range observable. This would 
suggest for the shikimate kinase that there is a slight change in the secondary 
structure of the protein, but no significant change in the tertiary structure. These 
results differ from the bench mark protein crystallography data published, however 
similar behaviour in the CD spectra for shikimate kinase has been observed in a 
related study [14]. These changes in the far UV region CD spectra for shikimate 
kinase upon ligand binding were attributed to an altering of the relative orientations of 
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the secondary structure, α-helices and β-sheets, rather than a change in the 
secondary structure content. These results suggest that the conformational changes 
observed in the higher order structure of these two proteins, are unobservable using 
conventional circular dichroism spectroscopy. 
 
4.3.4 Discussion 
Since the proteins are immobilised on the nanostructure surface through the binding 
of the His-tag to the NTA/EG-thiol self-assembled monolayer, the proteins are 
immobilised with a consistent orientation relative to the surface. Superchiral 
polarimetry has been shown to be sensitive to the anisotropy of chiral molecules, and 
has previously been used to distinguish between globular proteins, with high α-helical 
content, and more structurally anisotropic proteins, with high β-sheet content [15]. 
The two proteins, EPSP Synthase and shikimate kinase, do not undergo any 
significant changes to their secondary structure content upon ligand binding, but do 
undergo changes in the quaternary and tertiary structures respectively, as seen from 
the X-ray structures of both proteins. As circular dichroism measurements, and other 
chiroptical spectroscopy measurements, are typically only sensitive to the secondary 
structure content of proteins, and a much lesser extent tertiary structure, the changes 
that occur here upon ligand binding to the proteins cannot be detected using these 
methods. This is proven in the circular dichroism measurements shown for both 
example proteins in Figure 4.05. However, by employing the phenomenon of 
plasmonic polarimetry, ligand induced structural changes can be detected in the 
tertiary and quaternary structures of shikimate kinase and EPSP Synthase 
respectively, as shown in Figure 4.04. Figure 4.04(c) also shows the asymmetry 
values resulting from the addition of ligand solutions to the nanostructured surface, in 
the absence of any adsorbed protein. These results show that the ligand solutions 
alone, even though they contain chiral small molecules, do not have any significant 
effects on the ORD spectra produced. This is to be expected for the small molecules 
within the ligand solutions, as they occupy a much smaller volume of the available 
chiral fields. Hence, compared with the protein samples, have a much lesser impact 
on the fields, and do not produce any net chiral asymmetry. This reinforces the results 
induced by the protein structural changes, as it confirms that the asymmetry 
differences produced are due to the conformational changes of the protein upon 
ligand binding, without the ligand solutions contributing to the ∆∆𝜆 values.  
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The increased sensitivity of plasmonic polarimetry, to higher order structural changes 
in protein molecules, is due to the superchiral nature of the evanescent fields 
produced by the chiral nanostructures, compared with the circularly polarised light 
used in circular dichroism measurements. This means that the effective helical pitch 
of the chiral evanescent field matches the length scale of the higher order protein 
structure, typically 10-100 nm, a lot more closely than that of circularly polarised light. 
However, the sensitivity of plasmonic polarimetry relative to conventional optical 
spectroscopy techniques can in part be attributed to the quadrupolar contribution to 
optical activity [15]. Normally, conventional chiroptical phenomena such as circular 
dichroism is derived from the higher-order effects, with the largest of the contributions 
coming from the electric dipole-magnetic dipole (dipolar) and electric dipole-electric 
quadrupole (quadrupolar) interactions. However, the electric dipole-electric 
quadrupole interactions average to zero in achiral media. With conventional excitation 
by circularly polarised light in CD spectroscopy, the dipolar and quadrupolar terms 
can contribute to the optical activity with the same order of magnitude for anisotropic 
materials [16]. Alternatively, the superchiral fields produced around the chiral 
shuriken nanostructures here, can display steep field gradients. These steep field 
gradients were found by Efrima [17] to enhance any quadrupolar contributions, 
relative to the dipolar contributions, to optical activity. The influence of these gradients 
of localised electromagnetic fields around the chiral nanostructures on the 
quadrupolar contribution to optical activity, has been shown to increase the 
asymmetry factors produced for anisotropic media [17]. However, this will be further 
investigated for the chiral shuriken structures in chapters 5 and 6, using the coupled 
oscillator model described in chapter 3, to create a deeper understanding of any 
effects the dipolar and quadrupolar contributions have on the optical properties of the 
nanostructures.  
 
4.4 Conclusion 
In this chapter, we have introduced a new optical spectroscopy phenomenon, 
‘superchiral’ polarimetry, using injection moulded chiral shuriken nanostructures. This 
phenomenon shows the power of using chiral evanescent fields with enhanced chiral 
asymmetries for probing the higher order structures of biomolecules. Two proteins, 
EPSP Synthase and shikimate kinase, were used as exemplar systems to show the 
sensitivity of superchiral polarimetry as a probe into the changes induced upon ligand 
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binding. With both proteins undergoing higher order structural changes, in the tertiary 
and quaternary structure, with no changes in the secondary structure content.   
The sensitivity of this method to higher order structural changes, exploits the 
generation of superchiral fields around the chiral shuriken structures, combined with 
the chiral fields around the nanostructures displaying steep field gradients. Chirally 
sensitive spectroscopy methods, such as circular dichroism, are based on the 
differential interaction of left- and right-handed circularly polarised light, which results 
in them being inherently insensitive to higher order structural changes. The 
superchiral fields generated by our chiral shuriken nanostructures have been shown, 
through the electromagnetic modelling simulations (shown in chapter 3), to display a 
chiral asymmetry an order of magnitude greater than that of circularly polarised light. 
With the local chiral fields around the nanostructures displaying steep field gradients 
that enhance any quadrupolar contributions to optical activity, resulting in an increase 
in any asymmetry obtained for anisotropic media. This provides a rather simplistic 
interpretation of the data, and in chapters 5, 6, and 7, a greater understanding of the 
chiral nanostructure interactions will be developed using the coupled oscillator model 
described in chapter 3. 
In summary, the results shown throughout this chapter demonstrate that superchiral 
polarimetry can readily detect higher order structural changes in immobilised proteins, 
which cannot be measured with conventional CD spectroscopy. The conformational 
changes detected for the two exemplar proteins demonstrate that, in agreement with 
previous studies of this phenomenon [15], superchiral polarimetry is sensitive to any 
changes in the anisotropy of the protein structures. Hence, in effect, can detect any 
changes in the relative positions of the secondary structure units within the protein.  
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Chapter 5: Orientation Determination of Adsorbed 
Structurally Similar Affimers 
5.1 Introduction 
The orientation of biomolecules, such as proteins, on surfaces can be crucial for a 
range of biological functions. This interface functionality is reliant upon the orientation 
of the surface bound proteins, as in many cases the active sites of immobilised 
proteins are inaccessible to targets in the solution [1]. Not only this, but proteins at 
interfaces with controlled orientations have been shown to possess higher activity 
than surfaces where the proteins are bound in random orientations [2]. However, 
since interfaces consist of a relatively small amount of material, conventional 
chiroptical spectroscopy cannot be used to determine the protein orientation due to a 
lack of sensitivity. 
In this chapter, we will show how we can discriminate between three structurally 
similar protein fragments, called Affimers, adsorbed onto the metamaterial surface 
with differing orientations. In the previous chapter, the asymmetry parameter (∆∆𝜆), 
was interpreted as a way of detecting higher order structural changes in proteins. 
However, plasmonic polarimetry is a rather simplistic interpretation of the data, and 
produces much smaller changes when studied theoretically [3]. Here we will develop 
a greater understanding of the nanostructured system, using three new asymmetry 
parameters extracted from the experimental reflectance spectra. As the reflectance 
spectra from the chiral shuriken structures display plasmonic induced transparency 
(described in chapter 3), the experimental asymmetry parameter ∆∆𝑆 can be 
interpreted in a similar way to the previously used ∆∆𝜆. The experimental data can 
then be modelled, using the coupled oscillator model introduced in chapter 3, to 
provide two asymmetry parameters for the phase retardation of the bright and dark 
plasmonic modes, ∆∆𝜃 and ∆∆𝜙 respectively.  
We will show that by interpreting the reflectance data in this way, we can readily 
distinguish between the three structurally similar Affimer proteins when they are 
immobilised in different well-defined orientations. This phenomenon arises from the 
sensitivity of the phase retardation effects on the spatial arrangement of the Affimer 
molecules within the nearfield of the nanostructures. Hence, the immobilised Affimer 
proteins cause an asymmetry in the phase retardation between left- and right-handed 
structures due to the differential interaction of the chiral near fields with the chiral 
dielectric environment. 
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5.2 Affimers 
Affimers, unlike antibodies, are based upon non-immunoglobulin scaffolds, with 
around 20 different types of non-antibody scaffolds being known [4]. All Affimers 
consist of the same scaffold protein, based on either mammalian Stefin A or plant 
Cystatin A, with a homologous tertiary structure throughout. 
 
Figure 5.01 Ribbon representation of Affimer protein scaffold (PBD 4N6U), labelled with the 
positions of the inserted cysteines for the three different Affimers. 
 
All three Affimers used throughout this study were based on the plant cystatin 
scaffold, that creates a well-defined tertiary structure composed of an anti-parallel β-
sheet and a central helix, as shown in Figure 5.01. The scaffold produced by the 
Affimer proteins, has two binding loops which can be varied in the phage display 
library containing 1010 randomised sequences, that can be used to generate Affimers 
with high affinity surfaces (nM) for specific targets. However, the scaffold and binding 
loops of the Affimers have been engineered to contain no cysteine residues, which 
allows a cysteine to be inserted at a specific, unique site to provide a simple method 
of immobilising these Affimer molecules to surfaces with a known orientation [5]. 
Three variants of the Affimers have been used here (G65C, K67C, and H6C), with 
each one having the cysteine residue inserted into a different position. For G65C and 
K67C, the cysteine residue was inserted into the β-turn 3 loop of the Affimer, located 
on the opposite face to the binding loops, with the position of each only differing by 
two residues in the primary sequence. However, for the H6C Affimer, the cysteine 
residue was inserted into the C-terminus loop of the protein, shown in Figure 5.01. As 
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the binding loops can also be engineered, to provide specific binding of targets, two 
of the Affimer variants (G65C and K67C) were engineered to bind glutathione S-
transferase (GST), and one of the Affimers (H6C) was engineered to be specific for 
immunoglobulin G (IgG). The three otherwise structurally identical Affimer structures 
can be immobilised onto the gold surface of the nanostructures, through the thiol of 
the cysteine residue, with different well-defined orientations. 
 
5.3 Results and Discussion 
5.3.1 Measurement of Affimers 
As a measure for this new approach, three Affimer samples were obtained from 
Avacta life sciences. For each of the three Affimer variants, reflectance 
measurements were recorded at all stages of immobilisation and binding. This 
includes Affimer immobilisation, polyethylene glycol (PEG) filler immobilisation, and 
binding of target protein to Affimers (described in Appendix D). For each reflectance 
measurement, the average shifts were calculated as well as the separation 
asymmetry parameter, ∆∆𝑆, described in chapter 3. The average shift for each 
measurement is calculated as the average shift of the two dips in reflectance for left- 
(∆𝜆𝐿) and right-handed (∆𝜆𝑅) nanostructures, and then described as ∆𝜆𝐴𝑣𝑔 =
 (∆𝜆𝑅 +  ∆𝜆𝐿) 2⁄ . The average shift measurements that are recorded here, can be 
thought of as being analogous to conventional surface plasmon resonance 
measurements, and are dependent on the surface coverage of the material. Figure 
5.02 shows the average shift data, relative to buffer, for the initial immobilised Affimer, 
addition of the PEG filler, and binding of the relative target protein for all three Affimer 
variants. Upon initial binding of the Affimer, and addition of the PEG filler to the 
surface, all three Affimer variants (K67C, G65C, and H6C) produce an identical 
average shift value within experimental error. This shows that each of the three 
Affimer variants, as expected, have the same coverage on the nanostructure surface, 
due to them all containing the same protein scaffold. Meaning that the three different 
orientations would not be distinguishable using the average shift measurements 
obtained from the reflectance spectra. 
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Figure 5.02 Bar chart showing average shifts for 3 Affimers; K67C (blue), G65C (red), and 
H6C (green). Showing average shifts for immobilisation of Affimer, addition of PEG filler, and 
binding of target protein to Affimer (K67C and G65C bind GST, and H6C binds IgG), all relative 
to initial buffer measurement. The error bars represent the standard error calculated from 8 
spectra measurements. 
 
When the respective target protein is added, either GST or IgG, the Affimers that bind 
the different proteins do become distinguishable. However, the two Affimers that both 
bind GST as the target protein (K67C and G65C) are still unable to be separated 
using the average shift measurements shown in Figure 5.02. This is caused by the 
differences in size of the target proteins, as GST is a 25 kDa sized protein with IgG 
being 150 kDa in size. This difference in size means that it is easy to distinguish 
between binding of IgG and GST, hence between H6C and the two GST binders, 
whereas it remains impossible to see the difference between K67C and G65C, as 
they both bind the same GST target. 
To interpret the reflectance data measured for the three separate Affimer variants 
further, a separation asymmetry parameter is introduced, ∆∆𝑆, as described in 
chapter 3. This asymmetry parameter, like the ∆∆𝜆 parameter introduced for the ORD 
spectra in the previous chapter, can be used to quantify any chiral asymmetry effects 
upon the left- and right-handed nanostructures resulting from the adsorbed proteins. 
72 
 
 
Figure 5.03 Bar chart showing asymmetry values calculated for 3 Affimers; K67C (blue), 
G65C (red), and H6C (green). Showing asymmetry values for immobilisation of Affimer, 
addition of PEG filler, and binding of target protein to Affimer (K67C and G65C bind GST, and 
H6C binds IgG), all relative to initial buffer measurement. The error bars represent the 
standard error calculated from 8 spectra measurements. 
 
Figure 5.03 shows all ∆∆𝑆 values calculated for the immobilisation of the Affimers, 
addition of PEG filler, and binding of the target protein to immobilised Affimer for all 
three variants. Instantly, it can be seen that when the three different Affimers are 
immobilised on the nanostructure surface, they each give a unique response 
compared to what was observed for the average shift measurements. The results 
show, that even though all three Affimer variants share the same protein scaffold, by 
inserting the cysteine residue at a different position in the sequence, and hence 
changing the binding orientation of the Affimer to the surface, a significant difference 
in the separation asymmetry can be detected. Although the position of the cysteine 
residue in K67C and G65C only differs by two amino acid residues on the same β-
turn 3 loop, the difference in orientation of the two Affimers on the surface produces 
a substantial difference in the asymmetry parameter of the two variants. With the 
H6C, IgG binding variant His-tagged on the C-terminus loop, producing the largest 
response. When the PEG filler is added to the immobilised Affimers, there are small 
responses for all three variants. This suggests that the binding of the PEG to fill in 
any gaps on the surface of the nanostructures, changes the orientation of the Affimers 
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slightly causing a small change in the asymmetry value obtained. After this has 
occurred, the difference between the two Affimers with the cysteine inserted in the β-
turn 3 loop still produce significantly different responses to each other, however the 
H6C response becomes indistinguishable to the K67C variant. The responses from 
the three Affimers after the respective target proteins have been added, then again 
become three separate and distinct values, with the H6C Affimer producing the 
largest asymmetry overall, after IgG binding. This suggests that, before target protein 
binding to the respective Affimers, the orientation of the K67C and H6C Affimers are 
in similar orientations to each other, but then become easily identifiable after 
respective binding. Which is due to the differences of the two target proteins for both 
Affimer variants. 
 
5.3.2 Non-Target Binding 
To test the Affimer system, and as a control to see if IgG had as large an effect on 
non-IgG binding Affimers, IgG was added as a target solution to both the K67C and 
G65C Affimer variants. Both these Affimers are GST specific binders, and therefore 
should not bind any IgG at all. 
 
Figure 5.04 Bar charts showing (a) average shift, and (b) asymmetry for immobilised Affimer, 
addition of PEG filler, and addition of IgG target solution for GST binders, K67C (blue) and 
G65C (red), all relative to initial buffer measurements. The error bars represent the standard 
error calculated from 8 spectra measurements. 
 
Figure 5.04 shows the average shift, and asymmetry values for both GST binding 
Affimers (K67C and G65C) after immobilisation on the surface, addition of PEG filler, 
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and after the addition of the IgG target solution which is then rinsed with buffer. As 
expected, since both of these Affimers should not bind IgG at all due to their high 
affinity and selectivity for GST, there is no change in the ∆∆𝑆 values after exposure 
to the IgG solution. There are also no changes, within error, to the average shift values 
meaning that the IgG from the target solution does not adsorb on the substrate 
surface, due to it already being filled with the Affimers, and PEG filler. This shows that 
the changes seen in Figure 5.03, after the addition of the target solution to the 
immobilised Affimer surface, is due to the Affimer specifically binding the protein and 
not due to any other factors, such as the protein itself becoming immobilised on the 
nanostructure surface. 
 
5.3.3 Affimer Modelling 
To further test, and gain a fuller understanding of the behaviour of the chiral 
nanostructures in the presence of these Affimer proteins, the reflectance spectra were 
modelled using a classical model to describe the plasmonic induced transparency.  
 
Figure 5.05 Graphs showing (a) reflectance spectra for water (black), and salt solution 
(dashed coloured) for both left- and right-handed shuriken structures, and (b) reflectance 
spectra for buffer (black) and, the adsorbed G65C Affimer (dashed coloured) for both 
handedness of shuriken structures. To aid comparison, both salt solution and Affimer spectra 
have been shifted (solid coloured) to overlap the initial water/buffer spectra. 
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This model used to replicate the reflectance spectra, was described in chapters 2 and 
3, and is based on two coupled oscillators with variations of this approach having 
previously been reported [6, 7]. 
In Figure 5.05, salt solution spectra and Affimer spectra with similar refractive index 
shifts, relative to water/buffer, were compared for left- and right-handed shuriken 
structures. From this figure, it can be seen that, while the salt solution produces no 
significant change in the shape of the reflectance spectra relative to the water spectra, 
the adsorbed Affimer does produce a noticeable change in the shape relative to buffer 
in Figure 5.05(b). As this change in shape only happens for the adsorbed Affimer, 
and not for the achiral salt solutions, the Affimer is not only causing a shift due to the 
refractive index increase, but also affecting the reflectance properties of the left- and 
right-handed nanostructures. To measure these effects, the Affimer spectra for all 
three variants were modelled, as described and performed for the salt solutions data 
in chapter 3. However, only the data for the initial immobilisation of the Affimers were 
modelled, and not the spectra after the addition of the target protein.  
 
Table 5.01 Model parameter values used to fit the left- and right-handed reflectance spectra 
for all three Affimer variant results. 
 
 
Table 5.02 Asymmetry values for the five parameters used to fit the Affimer spectra; 𝜔𝑟, 𝜔𝑑, 
𝑘, 𝜃, and 𝜙. 
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Figure 5.06 Graphs showing measured reflectance spectra (black), and fitted spectra 
(coloured) for buffer and Affimer measurements for (a) G65C, (b) K67C, and (c) H6C. 
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Figure 5.06 shows the fitted data directly overlapping the experimentally measured 
reflectance spectra for buffer, and all three of the Affimer variants, showing the quality 
of the fitting achieved. From the fitting spectra achieved for all three Affimers, G65C, 
K67C, and H6C, the fitting parameters are shown in Table 5.01. The differences 
observed in the fitting for 𝜔𝑟, 𝜔𝑑, 𝑘, 𝜃, and 𝜙 are shown in Table 5.02, as well as the 
calculated asymmetry parameters for these quantities. With these asymmetry 
parameters being calculated as ∆∆𝑥 =  ∆𝑥 𝑅 − ∆𝑥𝐿 , where 𝑥 = 𝜔𝑟, 𝜔𝑑, 𝑘, 𝜃, and 𝜙. 
For all three of the Affimer variants, in different orientations, all the asymmetry 
parameters possess a non-zero value. This shows that the presence of the Affimers 
on the metamaterial surface has a differential effect on the reflectance properties of 
both the left- and right-handed nanostructures. The asymmetry parameters calculated 
and arranged in Table 5.02, show all asymmetry values for all five parameters. 
However, to further understand the significance of these values, they were plotted as 
three separate bar charts in Figure 5.07. As well as ∆∆𝜆 values, for all three Affimer 
variants, measured from the ORD spectra (Appendix D), as previously used in 
chapter 4. Figure 5.07(a) shows the ∆∆𝜆 values for the Affimers, which are small and 
within experimental error of each other, emphasising the similarity between the 
structure of all three Affimer variants. Three bar charts relating to the modelled 
parameters were then plotted, the first containing the asymmetry values in phase, 𝜃 
and 𝜙, the second containing the asymmetry values for 𝑘, and the last graph 
displaying the asymmetry values for 𝜔𝑟 and 𝜔𝑑 calculated for all three Affimer 
variants. The asymmetry parameters calculated from the fitting data for 𝑘, 𝜔𝑟, and 𝜔𝑑 
are shown in Figure 5.07(c) and (d). For all three of the Affimer variants fitted, the 
values for these three parameters were all the same, within experimental error. 
Meaning, all three of the Affimer orientations were indistinguishable using these 
calculated fitting parameters. However, it is worthy to note that the asymmetry values 
for 𝜔𝑟 and 𝜔𝑑 have opposite signs to each other, with the latter values being roughly 
1.5x larger than the 𝜔𝑟 values. In contrast to the obtained values for these three 
parameters, the asymmetry values in phase do differ significantly for each Affimer 
variant, as shown in Figure 5.07(b). As a result of these two phase parameters 
differing for each of the three Affimer variants, this provides a distinct fingerprint for 
the different Affimer orientations. Interestingly, when the cysteine residue was 
inserted into the β-turn 3 loop of the Affimer structure, the ∆∆𝜙 value is larger than 
∆∆𝜃. However, this is reversed for the H6C Affimer, where the cysteine residue is 
inserted into the C-terminus strand.  
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Figure 5.07 Bar graphs showing (a) ∆∆𝜆 values from ORD spectra, (b) phase parameter (𝜃 
and 𝜙) asymmetries, (c) coupling parameter (𝑘) asymmetry, and (d) resonance frequency (𝜔𝑟 
and 𝜔𝑑) asymmetries for all three Affimer variants. The error bars represent the standard error 
calculated from 8 spectra measurements. 
 
5.3.4 Discussion 
Two different interpretations of the reflectance data have been used throughout this 
chapter to determine the orientation differences of structurally similar Affimer proteins; 
the experimentally measured ∆∆𝑆 parameter, and the modelled retardation phase 
asymmetries, ∆∆𝜃 and ∆∆𝜙. The experimentally measured ∆∆𝑆 results, shown in 
Figure 5.03, show that this parameter can be used to distinguish between the different 
orientations of the same Affimer. Hence, even though the cysteine residue in G65C 
and K67C are only two positions in the sequence different, the two can easily be 
separated by the experimentally measured ∆∆𝑆 values. As the shape of the 
reflectance spectra is characteristic of plasmonic induced transparency, and is 
caused by the coupling of the optically bright dipolar and optically dark quadrupolar 
modes of the nanostructures (described in chapter 2). It has previously been shown, 
that any changes in the coupling between these two modes of the nanostructure 
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would have an effect on the shape and size of the reflectance spectra produced [8]. 
Due to the Affimer scaffold consisting of an α-helix, and anti-parallel β-sheet, the 
orientation of these secondary structure components can mediate the coupling 
between the two modes of the nanostructure. Since these secondary structure 
components are inherently chiral, the effect that the orientation of these structures 
has on the mediated coupling of the chiral nanostructures will be unequal for both the 
left- and right-handed shuriken structures. As the effect on each handedness of the 
nanostructure is asymmetrical, the induced changes in the reflectance spectra for 
both left- and right-handed structures will also be asymmetrical. Hence, with each of 
the Affimer variants being adsorbed to the surface with a different orientation, the 
separation effects in the two reflectance dips of the spectra for each handedness of 
structure will be unequal, resulting in the ∆∆𝑆 values observed in Figure 5.03. 
In addition to this, the results shown in Figures 5.02 and 5.04 suggest that there are 
no significant structural perturbations of the Affimer upon immobilisation to the gold 
surface, with the surface stability of the Affimer protein scaffold being well 
documented [9, 10]. Previous studies using the quartz crystal microbalance (QCM) 
have shown that if there are any significant structural changes to the Affimer scaffold 
upon adsorption to the gold surface, then a loss of affinity and specificity for the target 
protein would occur [11]. However, from the results shown in Figure 5.02, it can be 
seen that there are substantial average shifts when the target protein binds to the 
respective Affimer, with H6C experiencing a shift of 3.8 nm upon IgG binding, and 
both G65C and K67C experiencing an average shift of 0.9 nm when exposed to GST. 
When the GST binding Affimers were exposed to IgG, in Figure 5.04, there was no 
measurable binding of the protein, resulting in no average shift or ∆∆𝑆 response. 
These results are in agreement with the high binding affinities of the Affimers to their 
target proteins observed in previous studies immobilised using the same method [12], 
and was indicative of a lack of perturbation to the secondary and tertiary structure of 
the Affimer. 
Two significant differences between EIT in atomic systems, and plasmonic induced 
transparency are; coupling is achieved via nearfields for plasmonic induced 
transparency, and retardation effects become significant since the dimensions of the 
nanostructures used become comparable to the wavelength of light. Retardation is 
the effect of the phase difference between fields propagating from spatially separated 
regions of a nanostructure, giving rise to phase changes in the excited plasmon 
modes [13-15]. Since the chiral nanostructures can be shown to produce spatially 
varying superchiral fields (chapter 3), the sensitivity of the phase retardation effects, 
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shown in Figure 5.07(b), arise from the differential interaction of the superchiral near 
fields with a chiral dielectric. To validate that the changes seen in the phase 
retardation parameter in the reflectance spectra, result from the adsorption of the 
Affimer proteins, numerical EM simulations were performed. A 20 nm thick isotropic 
chiral dielectric layer covering the shuriken structures was simulated. The chiral 
dielectric layer was modelled based on the constitutive equations for an isotropic 
dielectric medium, previously reported, given by: 
𝑫 =  𝜀0𝜀𝑟𝑬 + 𝑖𝜉𝑩 
𝑯 =  𝑩 𝜇⁄ + 𝑖𝜉𝑬 
Here, 𝜀0 is the permittivity of free space, 𝜀𝑟 is the relative permittivity, 𝜇 is the 
permeability, 𝑩 is the complex magnetic flux density, 𝑯, 𝑬 and 𝑫 are the complex 
magnetic field, electric field and electric displacement field respectively, and 𝜉 is a 
local parameter describing the chiral property of a molecular layer. Since 𝜉 is a chiral 
descriptor, it only becomes a non-zero value for a chiral dielectric. Following a 
procedure previously described in the literature [16, 17], it can be calculated that for 
a protein layer, the parameter 𝜉 ≈ 5x10-4 for a wavelength of 700 nm. The simulation 
results are shown in Figure 5.08, and show the reflectance spectra for a chiral 
shuriken structure covered with water, and both the left- and right-handed shuriken 
structures covered with the chiral dielectric layer.  
 
Figure 5.08 (a) Reflectance spectra from simulation with chiral dielectric covered left- (red) 
and right-handed (blue) shuriken nanostructures, as well as water covered shuriken structure 
(black), and (b) asymmetry in phase parameters for the simulated chiral dielectric layer 
compared with the three Affimer samples. The error bars represent the standard error 
calculated from 8 spectra measurements. 
 
(5.3.1) 
(5.3.2) 
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These results clearly demonstrate changes in the reflectance spectra when a chiral 
dielectric was added. The simulated reflectance spectra were also fitted with the 
coupled oscillator model, used previously, to extract the phase parameters, with all 
the modelled values for the simulated data shown in Appendix D. From Figure 
5.08(b), an asymmetry in the phase parameters, 𝜃 and 𝜙, is observed from the left- 
and right-handed structures, which is comparable in size to that observed in the 
experimental data. However, these simulations are not an exact reproduction of the 
experimentally observed changes, and are intended only as a proof of principle, since 
the Affimer layers are not isotropic in nature. Hence, the orientation and physical 
coverage of the Affimer layer cannot be replicated in a simulated environment. Even 
so, the simulations involving the isotropic chiral dielectric in Figure 5.08(a), still 
provide validation that the phase retardation of the chiral plasmonic resonators are 
dependent on the chirality of the surrounding dielectric.  
The two main secondary structure protein motifs, α-helix and β-sheet, both differ in 
their dipole moments. The α-helix structure possesses a significant net dipole, which 
arises from the cumulative effect of the dipole moment of each amino acid backbone 
unit [18]. This is due to the peptide units in the α-helix all being aligned in the same 
orientation along the helical axis, resulting in the dipole moments also being aligned 
along this axis with a partial positive charge at the amino end, and a partial negative 
charge at the carboxy end. However, β-sheets are made up of β-strands that are 
aligned adjacent to each other, either parallel or anti-parallel. The anti-parallel β-
sheet, that is present for the Affimer, is made up by the amino acids in adjacent 
strands having alternating directions [19]. This means, as the β-strands are aligned 
in opposite directions, the dipole moments of each strand are also in opposing 
directions, causing a negligible dipole moment, but would have quadrupolar or higher 
multipole moments. Since the Affimer structures contain a high anti-parallel β-sheet 
content (~ 55%), and the anisotropic nature of the Affimer layer is important due to 
the higher order contributions to optical activity, which cannot be replicated in the 
simulated environment, it can be speculated that the experimentally observed 
orientation dependency of the phase asymmetries, are due to these higher order 
moments. 
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5.4 Conclusion 
In this chapter, we have introduced a new spectroscopic phenomenon to discriminate 
between protein fragments, which are structurally similar but immobilised on the gold 
nanostructures with differing orientations. The experimental asymmetry parameter, 
∆∆𝑆, extracted from the reflectance spectra measured for both left- and right-handed 
chiral shuriken structures, was shown to be sensitive to the orientation of these 
exemplar Affimer systems. However, two of the Affimer variants (K67C and H6C) both 
produced a similar response, which could then only be separated after the addition of 
the respective target binding proteins.  
By introducing a simple coupled oscillator model, described in chapters 2 and 3, the 
experimental reflectance spectra were modelled, and any retardation phase shifts 
extracted. These retardation phase shift asymmetries, ∆∆𝜃 and ∆∆𝜙, were then 
demonstrated to be sensitive to the differences in the immobilised orientation of the 
Affimers (Figure 5.07(b)). With these asymmetries in the retardation phase changes 
resulting from the differential interaction of the left- and right-handed chiral near fields 
of the structure with the chiral dielectric. When these results are compared with the 
asymmetry parameter (∆∆𝜆) introduced in the previous chapter, the results observed 
for ∆∆𝜆 are all small and within the experimental error for all three immobilised 
orientations of the Affimer proteins. This inability of the previously used ∆∆𝜆 
parameter to detect the small differences between the immobilised Affimer layers, 
shows the greater incisiveness of the phase asymmetries to the orientation of the 
surface bound proteins. This represents a new source of retardation effects that can 
be induced through the dielectric properties of the surrounding environment, which 
has previously been attributed solely to size/geometry effects of the nanostructures 
[14, 20]. 
In summary, we have demonstrated that exemplar proteins which have similar 
structures, and only differ by a single amino acid (G65C and K67C), can be 
distinguished from each other using the phase retardation fingerprints introduced 
throughout this chapter. The results presented here are a more sensitive probe to the 
geometric structure of protein layers than previous applications of chiral plasmonic 
fields. Which have only been able to discriminate between proteins with significantly 
different secondary structure [21]. This phenomenon is a valuable addition to current 
bioanalytical methods, as it provides a unique way to rapidly obtain a simple 
fingerprint of interfacial structure that would otherwise not be possible.  
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Chapter 6: Characterisation of Surface Orientation 
and Ligand Induced Conformational Changes for 
Heat Shock Protein 90 
6.1 Introduction 
High-throughput studies, and characterisation of target molecule binding to proteins 
is important for the discovery of effective drug targets. Current methods of 
determining protein-target interactions include; X-ray crystallography [1], nuclear 
magnetic resonance (NMR) [2], and label based fluorescence spectroscopy [3]. 
However, these methods are time consuming, and require a lot of material to work 
with. The labels required for fluorescence spectroscopy also often sterically hinder 
the molecular binding interactions with the protein, and leads to errors in the 
measurements [4]. This leads to the requirement for high-throughput label-free 
methods for the detection and characterisation of protein-target molecule interactions. 
In this chapter, we will use the phenomena introduced in the previous chapter; both 
the asymmetry parameter (∆∆𝑆), and the retardation phase asymmetries (∆∆𝜃 and 
∆∆𝜙) extracted from the reflectance spectra, to detect protein conformational changes 
upon binding of an inhibitor molecule. The protein, Heat Shock Protein 90 (HSP90), 
a therapeutic target for anti-cancer drugs, was immobilised on the chiral 
nanostructured surface with two differing orientations. The HSP90 inhibitor, 17-AAG, 
was used to bind to the surface immobilised protein, and induce an irreversible 
conformational change. We will show how we can detect the two different binding 
orientations of the immobilised protein, and then how the differing orientations of the 
HSP90 affect the sensitivity of the ligand induced conformational changes that can 
be detected.  
By modelling the spectra in the same way as described previously, we will show that 
the retardation phase shifts, ∆∆𝜃 and ∆∆𝜙, are not only sensitive to the orientations 
of the adsorbed protein molecule, demonstrated in the previous chapter, but are also 
sensitive to the ligand induced conformational changes. These phase shift 
parameters are in close agreement with the experimentally measured ∆∆𝑆 parameter 
for both protein orientations. Showing that both these phenomena are incisive probes 
into determining the ligand induced binding effects, especially when the protein is 
immobilised with an optimum orientation, and would be a powerful tool for high-
throughput drug discovery.  
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6.2 Heat Shock Protein 90 (HSP90) 
Heat shock protein 90 (HSP90) is one of the most abundant molecular chaperone 
proteins, which as a family, account for 1-2% of all cellular proteins in most cells [5]. 
The molecular chaperone HSP90, named as it protects cells from stress and is a 90 
kDa sized protein, stabilises and activates more than 200 proteins which are often 
referred to as HSP90 ‘clients’. Many cancer cells can use the HSP90 protein to protect 
an array of mutated or overexpressed cancer associated proteins from misfolding or 
degradation [6]. Therefore, HSP90 has been recognised as a crucial facilitator of 
cancer cell survival, and as a result has become a significant therapeutic target for 
cancer drug treatment [7]. The structure of HSP90 is a homodimer, with each 
protomer containing three flexibly linked regions; an N-terminal domain, a middle 
domain, and a C-terminal domain [8]. The homodimer, in its apo (open) state, adopts 
a V shaped structure, as shown in Figure 6.01(a). HSP90 is a weak ATPase, leading 
to induced conformational changes upon ATP binding. When ATP binds to HSP90, a 
series of conformational changes occur. The first intermediate is reached after initial 
ATP binding, where the ATP lids in the N-domains close over, but the domains still 
remain open in the V shaped conformation. The second intermediate is then reached, 
where the N-terminal dimerise, with the middle domains repositioning, shown in 
Figure 6.01(b). The HSP90 then reaches its fully closed structure, shown in Figure 
6.01(c), which is when the ATP is hydrolysed. After the hydrolysis of ATP, the N-
domains dissociate and release the ADP, before returning back to the initial open 
conformation [9, 10].  
Many therapeutic inhibitor molecules have been developed since HSP90 was 
identified as a target for cancer therapy, with one of the most prominent being the 
natural product, Geldanamycin. Part of the Ansamycin family, it binds to the ATP-
binding site of the N-terminal domain in HSP90, and disrupts the ATPase activity [11]. 
However, Geldanamycin is too toxic in treating patients directly. Therefore, 
derivatives of Geldanamycin have gained interest as a therapeutic inhibitor, with the 
17-allylamine derivative, 17-allylamino-17-demethoxygeldanamycin (17-AAG), being 
at the forefront of current research. Which has resulted in 17-AAG being the subject 
of multiple clinical trials [12]. 17-AAG is a small molecular inhibitor of HSP90 that 
inhibits the binding of HSP90 to client proteins by directly binding to the ATP/ADP 
binding pocket. When the inhibitors bind to the ATP/ADP binding pocket, the protein 
seems to mimic the ADP bound fully closed state, as shown in Figure 6.01(c). 17-
AAG has been shown previously to bind to purified HSP90 with a micromolar affinity, 
causing the full closure of the HSP90 protein described [13-15]. 
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Figure 6.01 Heat shock protein 90 dimers in (a) the open form (PDB: 2IOQ), (b) partly closed 
ATP-bound form (Intermediate 2, PDB: 2O1V), and (c) closed ATP-bound form (PDB: 2CG9). 
(d) and (e) show the relative immobilised orientation of the HSP90 protein when His-tagged 
at the C-terminus and N-terminus domain respectively. 
 
Figure 6.01 shows the three major conformations that occur upon HSP90 binding with 
ATP. First the open V shaped conformation, the intermediate partially closed ATP 
bound formation, and then finally the completely closed formation before releasing 
ADP and returning to the open conformation. The inhibitor, 17-AAG, binds to the 
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HSP90 protein inducing the full conformational closure, as shown in Figure 6.01(c). 
Two different variants of the HSP90 protein will be measured here, each with an 
identical structure but with the His-tag attached at a different position of the protein. 
The two variants have the His-tag attached at either the C-terminal domain, or on one 
of the N-terminal domains present within the protein. When the His-tag is attached to 
the C-terminal domain, the HSP90 is attached to the NTA monolayer with an 
orientation as shown in Figure 6.01(d). In this case, the C-terminal ‘hinge’ region is 
attached to the surface, through the His-tag, so that the N-terminal ATP binding 
domain is exposed to the solution, and the furthest part of the protein from the sample 
surface. The second variant, when the His-tag is attached to the N-terminal of the 
HSP90 protein, has the orientation of the protein reversed, shown in Figure 6.01(e). 
The N-terminal of one domain is attached to the nanostructure surface, through the 
His-tag, with the C-terminal now being furthest from the substrate surface. This 
means, that in the case of the N-terminal bound HSP90, the ATP binding site of one 
of the protomers is right next to the surface of the nanostructure. 
 
6.3 Results and Discussion 
6.3.1 Measurement of HSP90 and Ligand Addition 
Having two versions of the HSP90 protein, with the His-tag at a different position for 
each, allows us to further test these phenomena for orientation effects of larger 
proteins, combined with the ligand induced conformational changes. The HSP90 
protein was either His-tagged at the N-terminal or C-terminal domain, meaning that 
the protein would be attached to the nanostructure surface with two different 
orientations. The C-terminal domain attachment would be orientated with the ‘hinge’ 
domain attached to the surface, and the two ATP binding domains openly exposed 
away from the surface. Whereas, the N-terminal domain attachment is orientated with 
the ‘hinge’ domain furthest from the surface, and one of the ATP binding domains 
attached to the surface, with the other ATP binding domain in free space. For each of 
the HSP90 attachments, reflectance measurements were recorded after the 
immobilisation of the NTA/EG-thiol in the presence of buffer, as a reference. Then 
after the immobilisation of the HSP90 protein, and after the addition of each 
increasing concentration of the 17-AAG ligand. 
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Figure 6.02 Bar chart showing the separation asymmetry parameter for HSP90 His-tagged at 
the C-terminal domain (blue) and at the N-terminal domain (red) for the initial immobilisation 
of the protein, and the addition of the 17-AAG ligand with increasing concentrations. The error 
bars represent the standard error calculated from 8 spectra measurements. 
 
Figure 6.02 shows the separation asymmetry parameter, ∆∆𝑆, for the initial 
immobilisation of both variants of HSP90, C-terminus (blue) and N-terminus (red), 
and the asymmetry values measured when increasing concentrations of the 17-AAG 
ligand was added to each HSP90 orientation respectively. From these results, the two 
orientations of the immobilised HSP90 proteins can be easily separated by their ∆∆𝑆 
value shown in Figure 6.02. For the HSP90 protein attached through a His-tag at the 
C-terminus domain, the ∆∆𝑆 value is almost twice as large as the value measured for 
the HSP90 protein attached by a His-tag on one of the N-terminal domains. 
After the HSP90 proteins were immobilised onto the nanostructured surface, with the 
two different orientations, the 17-AAG ligand was introduced. Five different 
concentrations of 17-AAG solution were consecutively added to the immobilised 
HSP90. The smallest concentration introduced was 1 nM 17-AAG, increasing in one 
order of magnitude steps to a final concentration of 10 μM. The results in Figure 6.02 
show that the two HSP90 orientations show different results for binding of the 17-AAG 
ligand at each respective concentration. For the lowest concentration, 1 nM solution 
of 17-AAG, there is no change produced in the asymmetry parameter for the C-
terminus orientation of the protein. However, there is a larger increase in the 
asymmetry for the N-terminus immobilised protein upon addition of the low 
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concentration ligand solution. When the next three concentrations of 17-AAG were 
added (10 nM, 100 nM, and 1 μM), both HSP90 orientations showed similar changes 
in the ∆∆𝑆 parameter response. With the 10 nM concentration producing a small 
decrease in asymmetry for both, albeit with the N-terminus variant showing a slightly 
larger decrease, and then the 100 nM and 1 μM solutions having no effect on the 
asymmetry parameter within experimental error of the measurements. When the final 
10 μM ligand solution is added to the immobilised proteins, no change can be 
measured in the asymmetry parameter for the C-terminus HSP90. However, for the 
N-terminus variant of the protein, another relatively large decrease is the asymmetry 
parameter occurs relative to the previous solution. 
 
6.3.2 Control Measurements 
To confirm that the changes observed in the reflectance asymmetry parameter, ∆∆𝑆, 
are a result of the induced conformational changes upon HSP90 binding the 17-AAG 
ligand, DMSO solutions without the addition of the 17-AAG ligand were added to the 
immobilised protein layer. The solutions were made the same way as the inhibitor 
solution, by adding the respective volume of DMSO used to dissolve the 17-AAG 
ligand to buffer, to again create five solutions which were consecutively added to the 
immobilised protein. As the HSP90 attached to the surface through the N-terminal 
domain showed the largest changes, only this protein was measured with the DMSO 
test solutions. Hence, if no change was observed for this orientation it is highly likely 
that no change would also be detected for the C-terminal immobilised HSP90.  
 
Figure 6.03 Average shift and separation asymmetry parameter (∆∆𝑆) values for the N-
terminal attached HSP90 protein with the addition of control DMSO solutions (no 17-AAG 
inhibitor). The error bars represent the standard error calculated from 8 spectra 
measurements. 
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Figure 6.03 shows the average shift values and asymmetry parameter values for the 
N-terminal immobilised HSP90 protein, and when increasing concentrations of DMSO 
solutions (with no 17-AAG inhibitor) were added to the protein. From this data, the 
DMSO solutions, containing no 17-AAG ligand, do not have any effect on the average 
shift or asymmetry parameter obtained from the HSP90 protein immobilised onto the 
gold nanostructure surface. Since there are no changes, outside of experimental 
error, when the DMSO solutions are added, we can conclude that all the changes 
observed for the measurements in Figure 6.02 are solely due to the conformational 
changes induced in the protein upon ligand binding.  
 
6.3.3 HSP90 Modelling 
As with the Affimer data, the HSP90 data shown here was also modelled using the 
coupled oscillator model in the same way as the previous chapter. With the 
retardation phase asymmetry, ∆∆𝜃 and ∆∆𝜙, values being plotted in Figure 6.04. 
These results are plotted for both the His-tagged versions of the HSP90 proteins, and 
the change observed for each ligand solution for both variants. The asymmetry values 
for the other three parameters, 𝜔𝑟, 𝜔𝑑 and 𝑘, are also plotted in Figure 6.05.  
 
Figure 6.04 Bar graphs showing the asymmetry values of 𝜃 (red bars) and 𝜙 (green bars) for 
the C-terminal (blue background, top) and N-terminal (red background, bottom) attached 
HSP90 protein. The error bars represent the standard error calculated from 8 spectra 
measurements. 
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Figure 6.05 Bar graphs showing the asymmetries in the resonance frequencies (𝜔𝑟 and 𝜔𝑑), 
and coupling parameter (𝑘) for the C-terminal (blue) and N-terminal (red) attached HSP90. 
The error bars represent the standard error calculated from 8 spectra measurements. 
 
The results in Figure 6.04 show the asymmetry values obtained from the modelling 
for the two retardation phase values, 𝜃 and 𝜙, for both the C- and N-terminal attached 
proteins. For the C-terminal attached HSP90, 𝜃 does not significantly change 
throughout the addition of the increasing concentrations of ligand solution. However, 
the 𝜙 parameter follows a very similar trend to the experimental data in Figure 6.02, 
with one major difference. Where the data suggests that, in correspondence with the 
experimental data, the protein goes through an intermediate structure when the 10 
nM and 100 nM ligand solutions are added to the immobilised protein. Although, 
contrary to the experimental data for the C-terminal attached protein, a large change 
occurs when the 10 μM 17-AAG ligand solution is added. Which shows that although 
the full closure of the immobilised protein cannot be detected in this orientation 
experimentally, by modelling the recorded data it can easily be distinguished from the 
intermediate structure. For the N-terminal attached HSP90, which is the version of 
the protein attached through one of the ATP binding domains, the modelled data 
again compliments the experimentally measured asymmetries. The 𝜃 parameter 
again shows insignificant changes, with only small changes upon binding of the 17-
AAG. However, the 𝜙 changes show much larger differences for this orientation of 
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HSP90. Comparable to the experimental data, the initial 𝜙 value for immobilising the 
N-terminal attached HSP90 onto the nanostructure surface is much smaller than 
immobilising the C-terminal attached protein. When the smallest concentration ligand 
solution, 1 nM, is added to the N-terminal attached HSP90, a significantly large 
increase occurs when compared to the initial value of the immobilised protein. This 
agrees with the experimental data once again, and further suggests that at low 
concentrations, the ligand binds to the HPS90 causing a closure of the ATP lid without 
bringing together the arms of the protein. Then for the 10 nM, 100 nM, and 1 μM 
solutions with the N-terminal attached protein, there are small changes in the 𝜙 
asymmetry as it passes through the intermediate structure seen in Figure 6.01(b). 
Then finally, as seen in Figure 6.02 for the experimental data, there is a significant 
decrease in the 𝜙 asymmetry when the 10 μM solution is added and the coming 
together of the two N-terminal domains leads to the full closure of the two arms. 
For the three parameters in Figure 6.05, 𝜔𝑟, 𝜔𝑑 and 𝑘, the values obtained upon 
modelling the addition of the ligand solutions to each HSP90 orientation are the same, 
within experimental error, of the initial protein value. This is the same for both the C-
terminal, and N-terminal His-tagged proteins. Therefore, similar to the Affimer 
orientation detection, no ligand binding induced conformational changes could be 
determined from the modelling of the 𝜔𝑟, 𝜔𝑑, and 𝑘 parameters. The numerical values 
used for each parameter in the model are shown in Appendix E.   
 
6.3.4 Discussion 
To characterise the conformational changes induced by ligand binding upon the 
HSP90 protein, immobilised with two different orientations, two interpretations of the 
reflectance data were again used here, in parallel with the previous chapter. The 
experimentally measured ∆∆𝑆 parameter, and the modelled retardation phase 
asymmetries, ∆∆𝜃 and ∆∆𝜙. The experimentally measured results for ∆∆𝑆, shown in 
Figure 6.02, show that there is a considerably larger asymmetry for the C-terminal 
immobilised protein than for the N-terminal immobilised HSP90. This is a result of the 
orientation with which the proteins are immobilised, shown in Figure 6.01(d) and (e). 
For the HSP90 with the C-terminus His-tag, the protein is bound through the C-
terminus domain, which acts as a ‘hinge’ for bringing the two ‘arms’ of the protein 
together, with the two arms of the protein being orientated in similar directions, Figure 
6.01(d). This orientates the two middle and N-terminal domains of the HSP90 
structure in a similar fashion, and can be theorised to create a larger contribution to 
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the asymmetry, as the secondary structure of each ‘arm’ is orientated in a similar 
fashion. In contrast, the N-terminus attached HSP90, attached through a His-tag at 
the N-terminal domain on one of the HSP90 arms, has both arms of the protein 
orientated very differently relative to the surface. With one arm being directly attached 
to the surface, through the His-tag, and the other arm being in free space, Figure 
6.01(e). This means that both arms of the protein, relative to the nanostructure 
surface, will not have similar orientations. Hence, the secondary structure in each arm 
will not be orientated in the same direction, and will not collectively contribute to the 
asymmetry, leading to the smaller asymmetry value seen in Figure 6.02. 
As reported previously from the literature, full closure of the HSP90 protein occurs 
with micromolar affinity for the chosen ligand, 17-AAG [11, 15, 16]. However, from 
the results shown in Figure 6.02, it can be seen that there are small changes induced 
in the HSP90 structure, even at much lower ligand concentrations. This is particularly 
observed in the N-terminal variant of the HSP90 protein. This shows that smaller 
changes to the HSP90 protein, caused by the addition of low nanomolar 
concentrations of 17-AAG, can be detected when the protein is attached to the 
surface through the N-terminal domain, than through C-terminal domain attachment. 
This is due to the ATP binding site being within the N-terminal domain, so when the 
protein is immobilised on the surface through the N-terminal end, the ATP binding 
site is closer to the surface of the nanostructures. However, when the protein is 
attached through the C-terminal end, the ATP binding sites are the furthest part of the 
protein from the structured surface. Therefore, even by having only one of the N-
terminal domains of the protein attached to the surface, the effect any change in this 
site has on the superchiral fields around the nanostructure is larger than when the 
binding sites are an extended distance from the surface, as in the C-terminal 
attachment of HSP90. This change caused, by the introduction of the 1 nM ligand 
solution, is most likely inducing the closure of the ATP binding lid in the N-terminal 
domain, with no large change in the quaternary structure of the protein [9, 10]. Hence, 
no detectable change for the HSP90 protein attached through the C-terminal domain. 
When the 10 nM and 100 nM solutions of 17-AAG are added to both the attached 
proteins, it can be theorised that some small changes are occurring with the protein 
possibly going through an intermediate conformation such as that shown in Figure 
6.01(b). However, when the larger concentration solutions of the ligand are added, 
there is a small increase in the asymmetry for the C-terminal attached protein with 1 
μM 17-AAG, but the largest change is for the N-terminal attached protein after the 
addition of the 10 μM ligand solution. The change caused for the C-terminal attached 
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protein with the 1 μM solution of 17-AAG, could be the change from the intermediate 
structure to the fully closed structure, but the changes measured in the asymmetry 
parameter are too small to say this with certainty. When the 10 μM ligand solution is 
added to the N-terminal attached HSP90 however, the asymmetry decrease is much 
larger due to the protein conformation becoming the fully closed structure shown in 
Figure 6.01(c). This larger change for the HSP90 attached to the surface through the 
N-terminal domain is theorised to be due to the two arms of the protein fully closing, 
bringing the two opposite N-terminal domains together and aligning the secondary 
structure of each arm relative to the surface. The changes caused for the protein 
attached through the C-terminal domain are consistently smaller due to the fact that 
the protein is attached through the hinge domain, resulting in the two arms of HSP90 
behaving almost symmetrically upon ligand binding. 
Consistent with the experimentally measured parameter, ∆∆𝑆, the two different 
immobilised variants of the HSP90 protein can be easily distinguished using the 
modelled phase parameters, ∆∆𝜃 and ∆∆𝜙. With again, the retardation phase 
parameter ∆∆𝜙 being twice as large for the HSP90 protein immobilised at the C-
terminal end, than for the N-terminal immobilised version. When the addition of the 
17-AAG ligand solutions were modelled using the same method, the ∆∆𝜙 parameter 
shows a similar trend to the experimentally measured ∆∆𝑆 parameters. With the N-
terminal immobilised variant of the protein, two significant binding event cans be seen. 
The initial binding of the 17-AAG with the 1 nM solution, attributed to the closure of 
the ATP-lid in the N-terminal domain, and the full conformational closure of the two 
protein arms with the 10 μM ligand solution. Small increases in the ∆∆𝜙 parameter 
can also be seen with the ligand solutions between these two concentrations, 
signifying the intermediate structure (Figure 6.01(b)) before the full closure of the 
protein. When the C-terminal immobilised variant of the HSP90 protein is modelled, 
the ∆∆𝜙 parameter once again follows the same trend as the experimental ∆∆𝑆 
values. Where the initial binding of the 17-AAG ligand cannot be detected at the 1 nM 
concentration, but the intermediate structure can be observed for increasing ligand 
concentrations of 10 nM, 100 nM, and 1 μM. However, in contrast to the 
experimentally measured ∆∆𝑆 parameter, the final coming together of the two arms 
of the protein can be observed, with a significant decrease in the ∆∆𝜙 value.  
In both the experimental and modelled results, the initial immobilised orientation of 
the HSP90 protein can be easily distinguished, with the C-terminal attached protein 
producing a response nearly twice the magnitude of the N-terminal, in both ∆∆𝑆 and 
∆∆𝜙. The intermediate structure, can also be seen for both immobilised variants of 
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the protein, with the final conformational closure also being observed in the ∆∆𝜙 
values for both attachments. However, in both the ∆∆𝑆 and ∆∆𝜙 interpretations of the 
data, only the initial binding of the 17-AAG from the 1 nM solution could be observed 
for the N-terminal attached protein. This is due to the binding site of the 17-AAG being 
located in the N-terminal domain of the HSP90 structure, which results in the closure 
of the ATP binding lid upon ligand addition. As the superchiral fields only extend a 
limited distance from the nanostructure surface, and are much more intense nearer 
the nanostructure, the closer to the surface the binding event or conformational 
change occurs then the more sensitive to this the structures will be. Hence, when the 
protein is immobilised through the N-terminal domain, the binding site of the 17-AAG 
is directly above the nanostructured surface, leading to the detection of the ATP-lid 
closure. However, in the C-terminal attached HSP90 protein, the N-terminal domain 
is located a significant distance away from the nanostructure surface (Figure 6.01(d)), 
resulting in the loss of sensitivity to the initial ligand binding event. 
 
6.4 Conclusion 
In this chapter, we have utilised the phenomena introduced in the previous chapter to 
discriminate between two surface bound orientations of the HSP90 protein, and 
detect the conformational changes induced upon ligand binding to the immobilised 
proteins. By initially immobilising the protein on the nanostructured surface with two 
opposite orientations, we can see how the orientation of the HSP90 can affect the 
sensitivity achieved for the protein-ligand interactions. With the protein initially binding 
the inhibitor, 17-AAG, before passing through an intermediate structure (Figure 
6.01(b)), to reach the fully closed conformation shown in Figure 6.01(c) [17]. 
Both the experimentally measured ∆∆𝑆 parameter, and the modelled retardation 
phase parameters, introduced in the previous chapter, show the same trends for both 
immobilised HSP90 variants. With the two different immobilised orientations being 
easily distinguishable. However, for the C-terminal immobilised HSP90 the fully 
closed conformation of the protein was only detected through the modelled phase 
parameter and not the experimental ∆∆𝑆 parameter. Which again suggests the 
greater incisiveness of the phase retardation asymmetries to not only the orientations 
of surface immobilised protein molecules, but also to any conformational changes 
that occur within the immobilised structure. In contrast to the C-terminal domain 
attached HSP90, the results in both ∆∆𝑆 and the phase asymmetries for the protein 
immobilised through the N-terminal domain show an initial ligand binding event 
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occurring for the lowest concentration ligand solution of 1 nM. This can only be 
observed for the N-terminal variant of the HSP90 protein, as the ligand binding occurs 
at the nanostructure surface, where the superchiral field intensity is strongest. 
Resulting in a higher sensitivity to small changes, such as the ATP-lid closure in the 
N-domain of HSP90, than would be detected at a larger distance from the 
nanostructure surface.   
In summary, we have shown here, that by using the same chiral nanostructures 
described throughout this thesis, that the orientation of an immobilised protein on the 
surface of the structures can increase the sensitivity of this phenomena to protein-
ligand interactions. Although the experimental and modelled parameters do show an 
agreement throughout, the modelled parameter ∆∆ϕ shows a greater incisiveness to 
the conformational changes produced upon ligand binding to the HSP90 protein. A 
greater sensitivity to the initial binding of the ligand, 17-AAG, was also achieved 
through controlling the immobilisation orientation of the protein. Hence, we have 
shown here that the sensitivity of this phenomenon to protein-ligand interactions, and 
conformational changes, can be increased through the immobilisation orientation of 
the protein. Enabling us to detect even very small changes within the protein 
structure, that would otherwise be a very difficult and arduous measurement. 
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Chapter 7: Detection of Elevated Immunoglobulin G 
Levels in Human Serum 
7.1 Introduction 
Human blood serum contains more than 20,000 different proteins, varying in 
concentration from 50 g/l to less than 1 ng/l, with an overall protein concentration of 
~1 mM [1]. Detecting any changes in the protein content of human blood serum 
efficiently is an important tool for disease and infection diagnostics, as the levels of 
certain proteins can be related to specific disease states [2, 3]. However, this can be 
very difficult due to the vast number, and concentrations, of different proteins present 
in the serum samples. Two common approaches that have been previously used for 
serum analysis are; specific recognition of biomarkers (using antibodies), and overall 
serum analysis using electrophoresis. The trouble with using these methods is that 
specific antibodies must be developed, electrophoresis is relatively insensitive, and 
they can be difficult in quantifying the level of protein present [4-6]. This leaves the 
necessity for a fast and efficient method to detect elevated levels of specific proteins 
within human serum samples.  
In this chapter, we will show a simple and efficient method of detecting elevated levels 
of the antibody, immunoglobulin G (IgG) within human blood serum solutions. A self-
assembled monolayer is added to the nanostructure surface to create an anionic 
interface for protein binding. The composition of the protein layer formed, called the 
protein corona, will primarily contain the IgG protein due to the isoelectric point 
associated with the IgG structure. Serum solutions spiked with different 
concentrations of IgG are investigated and characterised, using the experimentally 
measured ∆∆𝑆 parameter, relative to stock serum solution. It will be shown from these 
results that low concentrations of spiked IgG can be detected, however higher 
concentrations of spiked IgG produce the same response as previous solutions, 
resulting in multiple IgG concentrations becoming indistinguishable from each other. 
Due to the protein corona being attracted to the self-assembled monolayer through 
electrostatic interactions, the sensitivity of these measurements can be tailored to 
higher IgG concentrations through the addition of sodium chloride (NaCl) to the serum 
solutions. Finally, we will show that this addition of NaCl to the serum solutions 
increases the electrostatic shielding involved in the system, lowering the coverage of 
the protein corona on the nanostructure surface. Allowing much higher concentrations 
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of IgG to be detected, pushing the limit of detection into the physiologically relevant 
range necessary for clinical applications. 
 
7.2 Human Blood Serum 
Human blood serum can be obtained from whole blood by removing the red and white 
blood cells, as well as the clotting factors, from the solution. Although there are a vast 
number of proteins present in human serum, the major constituents present are; 
albumin, immunoglobulins, transferrin, and lipoproteins [7]. With only ~20 of these 
proteins making up 99% of the serum protein content by mass [8]. 
 
Table 7.01 Table showing the concentration and isoelectric points of constituents present in 
stock human serum solution [9, 10]. 
 
Table 7.01 shows the constituent proteins, as well as their concentrations and 
isoelectric points, in the stock serum solution used throughout this chapter. From the 
table, it can be seen that over 50% of the protein present in the stock solution is 
albumin, with the immunoglobulins the next most abundant, followed by transferrin. 
Many other proteins are also present in the solution, however at very small 
concentrations. This makes human serum one of the most difficult protein containing 
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samples to characterise due to the dominance of albumin present, and the wide range 
in the abundance of other proteins present in the solution [8]. 
Although human serum consists of such a large variety of proteins, immunoglobulin 
G (IgG) is the main target protein being measured in this study. This is due to the 
levels of IgG present in the solution fluctuating with specific diseases and infections, 
allowing the diagnosis of these to be confirmed by quantifying the elevated 
concentration of IgG present within the serum solution. 
 
7.2.1 Immunoglobulin G (IgG) 
Immunoglobulin G (IgG) is a large antibody with a molecular weight of ~150 kDa. The 
protein is made up of two different polypeptide chains, a heavy chain of 50 kDa, and 
a light chain of 25 kDa. With each IgG antibody consisting of two heavy chains, and 
two light chains. 
 
Figure 7.01 (a) Crystal structure of immunoglobulin G antibody (PDB: 1IGT), and (b) showing 
the heavy chains (blue) and the light chains (green). 
 
Figure 7.01 shows the structure of immunoglobulin antibodies with the heavy and light 
chains identified in blue and green respectively. Where the two heavy chains are 
linked by disulphide bonds, with each heavy chain also being connected to a light 
chain by a disulphide bond [11]. There are five major immunoglobulin classes; IgM, 
IgD, IgG, IgA, and IgE, with IgG being by far the most abundant, making up nearly 
75% of all serum antibodies [12]. Even though IgG is one of the most abundant 
proteins in human serum solution, it is still only about a quarter of the amount of 
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albumin present by mass. This makes it difficult to selectively detect from the bulk 
serum solution containing the vast number of other proteins. However, IgG has a high 
isoelectric point (pI), on average 8.3, which means that in a solution of pH lower than 
that, the protein would carry a net positive charge. IgG is the only abundant protein 
in human serum that has a pI value that high, with the other most abundant proteins, 
albumin, transferrin and IgA, all having pI values below 7, Table 7.01. This means 
that at the normal pH of blood serum, pH 7.4, IgG would be the only abundant protein 
to have a net positive charge, with the others all possessing a net negative charge. 
The differing isoelectric points of the abundant proteins within human serum is one of 
the properties exploited for separation by electrophoresis, and isoelectric focusing 
[13], and will be used here to selectively immobilise IgG on the nanostructured 
surface. 
For various diseases and infections, certain protein levels within human blood serum 
can be altered. Previous studies have shown that elevated levels of IgG in serum can 
be a sign of fast progression cystic fibrosis in children [14], chronic liver disease [15], 
and autoimmune hepatitis [16]. With the amount that IgG is elevated by, being used 
to distinguish between chronic conditions, and autoimmune conditions [15, 17]. 
Hence, a simple and efficient method to quantify the level of IgG present in any serum 
sample would be of benefit for many medical diagnostic applications. 
 
7.2.2 Protein Corona 
When proteins from the serum samples adsorb to the nanostructure surface, the 
resulting protein layer is called the protein corona. The structure and composition of 
this protein corona can depend on many of the properties of the metamaterial, such 
as the size and shape of the nanostructures, as well as the functionalisation of the 
surface. The competitive adsorption of the proteins from the serum solutions on the 
nanostructure surface is based on the abundance and affinities of the proteins in the 
solutions, with this effect being known as the Vroman effect [18, 19]. In the Vroman 
effect, firstly the most abundant proteins are adsorbed to the nanostructure surface, 
and are replaced over time by the proteins with higher affinities. However, the results 
shown in Figure 7.02 and reported previously in other studies, show that when the 
surface is covered with negatively charged particles, proteins with isoelectric points 
above the pH of the solution (such as IgG) predominantly bind to the surface [20]. 
Hence by functionalising the nanostructures with NTA, the composition of the protein 
corona for serum solutions is altered to be predominantly made up of IgG. 
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7.3 Results and Discussion 
A nitrilotriacetic acid (NTA) monolayer was added to the surface with no spacer 
molecule, to give complete NTA coverage, and without the addition of the Ni2+ solution 
described in chapter 3. By forming the monolayer in this way, a completely anionic 
surface is created on the nanostructure surface. This should allow us to enhance the 
adsorption of the IgG protein to the surface, compared with any of the other abundant 
proteins within the serum samples. To view the binding characteristics of the target 
protein (IgG), and the most abundant protein in human serum (Albumin), solutions of 
both proteins, of increasing concentrations, were made up in 10 mM Tris buffer and 
added to the surface. With the average shift and ∆∆𝑆 values plotted in Figure 7.02.  
 
Figure 7.02 Average shift (top), and separation asymmetry (bottom) values for solutions of 
(a) immunoglobulin G (left, blue background), and (b) human serum albumin (right, orange 
background) in 10 mM Tris buffer. (c) Graphical description of protein corona composition for 
two IgG concentrations depicted by the arrows from part (a). The error bars represent the 
standard error calculated from 8 spectra measurements. 
104 
 
As described in chapter 3, the average shift parameter is an analogue of a surface 
plasmon resonance measurement, describing the coverage of the adsorbed layer on 
the metamaterial surface. The average shift results in Figure 7.02 show that, when a 
pure solution of IgG is added to the functionalised nanostructures, IgG is adsorbed 
on the anionic ligand with the coverage increasing as the protein concentration 
increases. However, both the average shift data, and the asymmetry values 
measured for the human serum albumin solutions, show that any albumin that is 
adsorbed is below the detection limit of the system. The asymmetry parameters for 
the IgG solution, which does adsorb to the surface, show an increasing asymmetry 
with increasing concentrations, but begins to decrease again as the solution reaches 
its highest concentration. We theorise that this decrease in the asymmetry value at 
higher concentrations of IgG, is a result of the increasing coverage of the protein on 
the nanostructure surface. It has been shown in the previous chapters, that the 
orientation of the proteins adsorbed on the chiral shuriken surface has a large effect 
on the magnitude of the asymmetry value produced, with the protein arrangement 
and orientation being a key factor in the composition of the protein corona [21-24]. At 
lower protein concentrations, when the coverage on the surface is smaller, the 
adsorbed proteins will be able to all align in a similar orientation leading to an increase 
in the asymmetry parameter value. However, at higher concentration solutions, where 
there is a greater coverage at the surface, it is theorised that the proteins will be more 
tightly packed leading to a more isotropic layer at the nanostructure surface (Figure 
7.02(c)), and a decrease in the separation parameter observed, as seen for solutions 
of IgG in Figure 7.02(a). 
 
7.3.1 IgG Spiked Serum Measurements 
To test the capability of this approach for measuring elevated protein levels in human 
serum, five different concentrations of IgG spiked serum were made from a stock 
serum solution with a total protein concentration of 60 g/L. The normal level of IgG in 
blood serum, and the percentage in the stock serum solution purchased, is ~15.3% 
of the total protein content by mass. The stock solution was then spiked with IgG to 
give a total IgG concentration in the solutions of 16.1%, 17.0%, 18.6%, 21.1%, and 
23.6% by mass. Each solution was diluted in 10 mM Tris buffer, pH 7.4, to give 
solution concentrations ranging from 3 g/L to 3x10-4 g/L. The separation asymmetry, 
ΔΔS, for each measurement in the reflectance spectra was calculated as described 
in the previous chapters. 
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Figure 7.03 Graphs showing (a) average shifts, and (b) asymmetry values for increasing total 
protein concentration for stock serum solution, and all IgG spiked serum solutions diluted in 
Tris buffer. The error bars represent the standard error calculated from 8 spectra 
measurements. 
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Figure 7.03 shows the experimentally measured average shifts, and asymmetry 
values for the stock serum solution, and all the IgG spiked serum solutions with 
increasing concentrations. When looking at the average shift data for stock serum, 
and all IgG spiked concentrations, they all produce the same average shift profile, 
with the highest protein concentration solutions showing a coverage with an average 
shift of ~4 nm. This shows that the coverage of the protein corona at the nanostructure 
surface is the same for each of the solutions, and hence any changes that can be 
observed for each solution is due to the composition of the protein corona changing 
rather than the coverage. 
The separation asymmetry results, ∆∆𝑆, show that at the two lowest protein 
concentrations for all solutions, no asymmetry change was detected within 
experimental error. However, for the stock serum solution, the asymmetry value 
begins to increase with the 0.03 g/L solution, and continues increasing with the 0.3 
g/L solution. Once the highest protein concentration solution is added to the 
nanostructure surface, 3 g/L solution, the asymmetry value decreases again back to 
zero. This behaviour is similar to the IgG only solution shown in Figure 7.02, and 
again is a consequence of the increased IgG concentration at the surface, creating a 
more isotropic environment. All five of the spiked serum solutions (shown in red, blue, 
green, grey, and orange in Figure 7.03) follow the same trend originally. Hence, for 
all solutions there is a zero asymmetry value for the lowest concentration of solution, 
with the asymmetry parameter increasing up to the 0.03 g/L concentrated solution. 
However, the spiked solutions then begin to be separated at the 0.3 g/L concentration, 
with the largest differences being observable at the top concentration of 3 g/L. At this 
highest concentration, all five spiked serum solutions are easily separable from the 
stock serum solution, containing only 15.3% IgG. The lowest spiked concentration, 
with a total IgG content of 16.1%, still shows a decrease in the asymmetry parameter 
going from 0.3 g/L to 3 g/L. However, this decrease is much less, and still gives an 
asymmetry value of 0.4 nm above the stock solution at this concentration. When the 
next two spiked serum solutions are added, 17.0% and 18.6% total IgG content, the 
asymmetry separation continues to increase between the 0.3 g/L and 3 g/L 
concentrations. Both of these spiked serum solutions, at the highest concentration 
solution, increase to an asymmetry value of ~1.0 nm above the stock serum solution. 
However, with the two highest spiked serum solutions, containing 21.1% and 23.6% 
IgG, the asymmetry values begin to decline again from the peak value produced at 
the highest concentration. This results in the asymmetry values for the highest 
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concentration solution being 0.6 nm and 0.5 nm for the 21.1% and 23.6% spiked 
solutions respectively. 
Since all the IgG spiked serums are inseparable at the lower concentrations of each 
solution, the higher concentration solutions are where the different IgG contents 
become distinguishable, and can be used for quantitative measurements. As the 
highest concentration solution of each spiked serum sample, 3 g/L, shows the 
greatest discrimination between samples and the stock serum solution, we can plot 
the asymmetry value produced at this concentration against the IgG content of each 
spiked serum. By taking the asymmetry parameter from each spiked solution at the 
highest total protein concentration, and plotting it against the IgG content of that 
solution, it is easy to see the quantitative sensitivity of these measurements. Figure 
7.04 shows the asymmetry parameter from the 3 g/L solution of each serum sample, 
with the stock solution containing 15.3% IgG content by mass. With the five other 
spiked solutions containing 16.1%, 17.0%, 18.6%, 21.1%, and 23.6% IgG.  
 
Figure 7.04 Graph showing the asymmetry value for the highest concentration solution of 
each spiked sample. Red background region shows the physiologically elevated levels of IgG 
in human serum. The error bars represent the standard error calculated from 8 spectra 
measurements. 
 
The results in Figure 7.04 show that from stock serum solution (first point, 15.3% IgG), 
there is a steady increase in the asymmetry value produced by spiking human serum 
with IgG. However, once the concentration of IgG in the serum sample reaches ~19%, 
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the asymmetry parameter value begins to drop again. With the asymmetry value 
achieved for the highest IgG spiked solution being 0.5 nm, down from 0.9 nm for the 
18.6% IgG serum solution. As the protein corona will also contain proteins other than 
IgG, the coverage remains the same with increasing IgG concentration, however the 
composition will differ. The area in Figure 7.04 with the red background is the region 
where the increase in IgG becomes physiologically relevant, with these levels being 
measurably higher than seen in the normal range [25]. In this case, the lower 
concentrations can easily be detected, with the asymmetry value gradually increasing 
as the IgG content increases, showing that the sensitivity of the method is suitable for 
these measurements. However, the current results show that detection of 
physiologically high levels of IgG are not possible, with the asymmetry parameter 
decreasing as the concentration of IgG reaches this range. Since the asymmetry 
value decreases again after a certain concentration of IgG, it becomes very difficult 
to separate samples, as two (or more) samples with different IgG concentrations 
would produce the same response. Hence, it would be difficult when measuring a 
sample of unknown concentration to tell if the IgG content was 16.5% or 23.5% for 
example, as these would produce the same ~0.5 nm response for both 
measurements.  
 
7.3.2 Saline Buffered Spiked Serum Measurements 
In the previous section, section 7.3.1, the serum solutions were all diluted using 10 
mM Tris buffer. In the following results, both the stock serum and all IgG spiked serum 
solutions were diluted in 10 mM Tris-saline buffer, containing 150 mM sodium chloride 
(NaCl). The solutions were prepared in the same way as in section 7.3.1, but diluted 
with Tris-saline buffer, to give three IgG spiked concentrations of 18.6%, 21.1%, 
23.6% by mass (the three highest concentrations used in the previous 
measurements). Sodium chloride was added to the dilution buffer used for each 
serum solution, to increase the ionic strength of the system. Hence, increasing the 
ionic strength of the solution, with 150 mM NaCl, resulted in lower protein adsorption 
to the functionalised surface, as a result of electrostatic screening lowering the 
electrostatic interactions between the functionalised surface and the proteins in 
solution. 
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Figure 7.05 Graphs showing (a) average shifts, and (b) asymmetry values for increasing total 
protein concentration for stock serum solution, and all IgG spiked serum solutions diluted in 
Tris-saline buffer. The error bars represent the standard error calculated from 8 spectra 
measurements. 
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The results in Figure 7.05 show the experimentally measured average shifts and 
asymmetry values for the stock serum solution, and IgG spiked solutions of increasing 
concentrations, diluted in Tris-saline buffer. The average shift values when the 
solutions are diluted in a Tris-saline buffer still show a similar profile for every solution, 
however the coverage at the highest, 3 g/L, protein concentration solution only shows 
an average shift value of ~1.5 nm. This is considerably smaller than the ~4 nm 
average shift value produced for the Tris buffer diluted samples in Figure 7.03. The 
stock serum solutions, and IgG spiked solutions with IgG contents of 18.6% and 
21.1% all show very similar asymmetry profiles to each other, suggesting that only 
minimal increased IgG binding is occurring on the nanostructure surface as the 
concentration of IgG in the solution increases. However, when the IgG concentration 
in the serum solution is raised to 23.6%, the asymmetry value begins to rise again 
until it reaches 0.5 nm at a total protein concentration of 3 g/L. This, suggests that 
when the IgG content in the serum solution reaches a suitably high level, the 
concentration of IgG present in the protein corona also increases. However, unlike 
the 23.6% IgG content solution diluted in Tris buffer in Figure 7.03, the concentration 
of IgG in the corona is still relatively low and therefore can still adsorb freely to the 
charged surface, leading to the increase in the ∆∆𝑆 asymmetry seen in Figure 7.05. 
As the average shift values do not change when solutions with an increased 
concentration of IgG are added to the system, we can again conclude that the 
differences being observed here are purely down to the composition of the protein 
corona changing (to include a higher concentration of IgG), rather than a higher 
protein coverage. 
In the same way as was done for the Tris buffer diluted serum samples, the 
asymmetry value for the stock serum solution and IgG spiked serum solutions diluted 
in Tris-saline buffer were plotted against the IgG content of each solution. These 
results are plotted in Figure 7.06, along with the previous results from the Tris buffer 
only dilutions, shown in Figure 7.04. The solutions diluted in Tris buffer only (no 
addition of NaCl) are shown in grey, where the solutions diluted in Tris-saline buffer 
are shown in purple for the same IgG spiked concentrations between each buffer. 
The same red highlighted area signifying the concentration where the IgG increase 
becomes physiologically relevant is also included from Figure 7.04. 
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Figure 7.06 Graph showing the asymmetry value for the highest concentration solution of 
each spiked sample for Tris buffer only dilutions (grey), and Tris-saline buffer dilutions 
(purple). Red background region shows the physiologically elevated levels of IgG in human 
serum. The error bars represent the standard error calculated from 8 spectra measurements. 
 
When the separation asymmetry results for the Tris-saline diluted solutions are 
plotted against the IgG content, as shown in Figure 7.06, the differences between 
diluting the samples in Tris buffer only, or Tris-saline buffer become much more 
distinguished. As discussed previously, when the samples are diluted in Tris-buffer 
only, the separation asymmetry increases as the IgG content initially increases from 
stock serum solution, but then begins to decrease again after an IgG content of 
18.6%. Meaning that multiple solutions with different IgG contents become 
indistinguishable from each other. However, when the IgG spiked serum solutions are 
diluted in Tris-saline buffer, the behaviour of the separation asymmetry varies 
completely from the Tris buffer solutions. When the spiked solutions are diluted with 
the Tris-saline buffer solution, the separation asymmetry continues to increase with 
increasing IgG content all the way up to the highest concentration of 23.6% IgG. In 
contrast to the solutions diluted by the Tris buffer only, each different IgG 
concentrated solution produces a gradual increase in the asymmetry value, including 
for the high physiologically relevant concentrations (23.6% IgG), shown by the red 
bar in Figure 7.06. This addition of 150 mM NaCl to the dilution buffer, increases the 
concentrations of IgG that can be detected in the spiked serum samples, and pushes 
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the limits into the clinically relevant range that would be required for the quantitative 
analysis of elevated IgG samples in commercial and clinical applications. 
 
7.3.3 Non-IgG Spiked Serum Solutions 
As control measurements, to validate the enhanced adsorption of IgG over other 
serum proteins, the stock serum solutions were spiked with three other highly 
abundant serum proteins; Albumin, Transferrin, and Immunoglobulin A (IgA). 
However, in contrast to IgG, the isoelectric points of these three serum proteins are 
all lower than that of IgG, resulting in all three having a net negative charge in the 
dilution buffers of pH 7.4. The solutions were prepared identically to the IgG spiked 
serum samples, with the respective protein (either albumin, transferrin, or IgA) being 
added to the stock solution and the total protein concentration remaining at 3 g/L. 
These solutions were once again diluted using either Tris buffer or Tris-saline buffer 
in order of magnitude steps to 3x10-4 g/L concentration. 
 
Figure 7.07 Graph showing the asymmetry parameters for increasing total protein 
concentration for stock serum (black), Albumin spiked serum (pink), Transferrin spiked serum 
(purple), and IgA spiked serum (maroon) diluted in Tris buffer. IgG spiked solution containing 
17.0% IgG, and diluted in Tris buffer, shown for comparison purposes. The error bars 
represent the standard error calculated from 8 spectra measurements. 
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Figure 7.08 Graph showing asymmetry parameters for increasing total protein concentration 
for stock serum (black), Albumin spiked serum (pink), Transferrin spiked serum (purple), and 
IgA spiked serum (maroon) diluted in Tris-saline buffer. IgG spiked solution containing 23.6% 
IgG, and diluted in Tris-saline buffer, shown for comparison purposes. The error bars 
represent the standard error calculated from 8 spectra measurements. 
 
Figures 7.07 and 7.08 show the separation asymmetry values obtained when the 
stock serum solutions were spiked with albumin, transferrin, and IgA, and diluted 
using Tris buffer or Tris-saline buffer respectively. In both figures, the IgG 
concentration that showed the largest asymmetry value at the highest protein 
concentration for each dilution buffer has been added for comparison. In the Tris 
buffer diluted serums, all three of the albumin, transferrin and IgA spiked solutions 
show no change (within experimental error) relative to the stock serum solution. In 
the case of the albumin, transferrin, and IgA spiked solutions diluted in Tris-saline 
buffer, there are also no changes within experimental error of the respective stock 
serum solution. For both cases, the IgG spiked serum shown produces much larger 
asymmetry values than any of the other spiked protein serum solutions. Even though 
Albumin is the most abundant protein, making up over 50% of the total protein content 
in serum, and IgA is the next most abundant immunoglobulin protein present after 
IgG. Showing that this method of binding to the nanostructure surface, and measuring 
the separation asymmetry, is solely sensitive to the IgG content of the human serum 
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solution, which is a result of the isoelectric points of each protein and the anionic 
ligand attached to the nanostructure surface. 
 
7.3.4 Discussion 
When the ideal protein solutions, both IgG and human serum albumin, were added to 
the functionalised nanostructure surface, only binding of IgG from the bulk solution 
was detected. With any albumin adsorption below the detection limit of the system. 
This is shown by the average shift data, which shows the increasing coverage of IgG 
on the nanostructure surface, with increasing protein concentration. However, the 
average shift with increasing albumin concentration, as well as the asymmetry value, 
does not increase out with experimental error. When the asymmetry parameter, ∆∆𝑆, 
for the pure IgG solution is measured, it shows an increase in separation with 
increasing protein concentration, until the final solution of highest concentration, 
where the asymmetry value decrease once again. This decrease in the separation 
asymmetry at higher IgG solution concentrations, is a consequence of the increased 
surface coverage of the protein. It has been shown in previous chapters of this thesis 
that the orientation of adsorbed proteins can have a large effect on the magnitude of 
the ∆∆𝑆 values observed. Hence, at the lower concentration solutions, the coverage 
of the protein at the nanostructure surface is small, which allows the IgG molecules 
to align in their preferred orientation, and leads to an increase in the asymmetry 
parameter measured. However, when the concentration of the IgG adsorbed on the 
nanostructure surface is sufficiently high, there is an increased coverage (shown in 
Figure 7.02(a)), resulting in the proteins being more tightly packed and randomly 
orientated, Figure 7.02(c). Which leads to the observed decrease in ∆∆𝑆 at high IgG 
concentration.   
When the serum solutions were diluted with Tris buffer, shown in Figure 7.03, the 
shape of the asymmetry values, with increasing protein concentration, produce the 
same trend as the pure IgG solution. With the average coverage of the protein corona 
remaining the same, ~4 nm, upon spiking the solution with increasing concentrations 
of IgG. Showing that, since the protein corona will also consist of other proteins from 
the serum solution, the asymmetry parameter ∆∆𝑆, for each increasing IgG spiked 
solution, is sensitive to the composition of the protein corona, and not to the overall 
surface coverage. Hence, increased concentrations of IgG will be displacing other 
proteins from the corona layer, meaning the coverage remains the same but with an 
increased concentration of IgG present within the protein corona. 
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Figure 7.09 (a) Asymmetry values for the highest concentration solutions diluted in Tris buffer 
(grey), and Tris-saline buffer (purple) for increasing spiked IgG contents. Graphical depiction 
of the protein corona for the 23.6% elevated IgG serum solution diluted in (b) Tris buffer, and 
(c) Tris-saline buffer. The error bars represent the standard error calculated from 8 spectra 
measurements. 
 
The shape of the graph shown in Figure 7.09(a), when diluted in Tris buffer (grey line) 
can be regarded as being due to the concentration of IgG present within the protein 
corona. When the IgG content in the solutions increases, the amount of IgG within 
the corona also increases, but is still sufficiently low to allow ordering of the adsorbed 
IgG below a concentration of 19.0% IgG. This allows the gradual increase in the 
asymmetry value when increasing the IgG content in the serum solution. However, 
when the IgG content in the solution increases above ~19.0%, the IgG content of the 
protein corona increases further, and results in a tightly packed isotropic layer, as 
shown in Figure 7.09(b). When the composition of the protein corona contains a high 
concentration of IgG, relative to other serum proteins, the corona continues to 
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become increasingly more disordered. Which results in the asymmetry value 
continuing to decrease, for the solutions from 19.0% to 23.6%, in a similar fashion as 
seen in Figure 7.02 for pure IgG solutions of increasing concentration. Hence, two 
serum solutions containing differing levels of IgG, such as 16.5% and 23.5% would 
produce the same asymmetry response, and would be indistinguishable from each 
other. 
When the serum solutions are diluted with Tris-saline buffer, containing 150 mM NaCl, 
the coverage of the protein corona decreases to ~1.5 nm, as shown in Figure 7.05. 
This decrease in the coverage of the protein corona, to less than half the initial 
coverage, is a result of the increased ionic strength of the dilution buffer. Hence, the 
increased ionic strength of the solution increases the electrostatic shielding between 
the proteins in solution and the surface charge of the anionic ligand, and results in a 
decrease in the amount of adsorbed protein within the corona layer [26]. Since the 
amount of adsorbed protein within the corona layer is decreased, the effective 
concentration of IgG present within this layer is also lower than that of the Tris buffer 
diluted samples, shown in Figure 7.09(c). When the two 23.6% IgG solutions diluted 
in either Tris buffer or Tris-saline buffer are added to the nanostructure surface, the 
hypothesised corona model can be seen in Figure 7.09(b) and (c). Due to the high 
concentration of IgG present in the serum solution, when diluted with Tris buffer the 
IgG content of the protein corona is high, resulting in the IgG being tightly packed and 
disordered within the corona layer. However, when the same high IgG concentration 
solution was added, diluted in Tris-saline buffer, the effective concentration of IgG 
within the corona layer is decreased, resulting in a more ordered protein layer 
adsorbed on the surface for the same bulk solution concentration, Figure 7.09(c). 
Hence, since the chiral fields around the nanostructure are sensitive to the orientation 
and alignment of the proteins immobilised at the nanostructure surface, as shown 
throughout this thesis, lowering the effective concentration within the protein corona 
allows the proteins to adsorb to the surface in their preferred orientation.  This allows 
the detection of sufficiently high concentrations of elevated IgG in human serum to be 
experimentally measured, and raises the level of detection possible into the 
physiologically relevant range required for many diagnostic applications.  
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7.4 Conclusion 
In this chapter, we have further developed the use of the ∆∆𝑆 parameter introduced 
in the previous two chapters. However, in this chapter we have introduced the addition 
of a complex real life solution, human blood serum, which contains a multitude of 
different proteins at varying concentrations. Human blood serum was spiked with 
increasing concentrations of IgG, and two dilution buffers of differing ionic strengths 
were used to dilute the serum solutions.  
When the serum solutions were diluted with Tris buffer (no NaCl added), an increase 
in the ∆∆𝑆 value was initially observed at lower spiked concentrations. However, when 
the elevated IgG levels increased into the physiologically relevant concentration 
range, a decrease in the ∆∆𝑆 value was observed, making these solutions 
indistinguishable from solutions of lower spiked levels. The coverage of the protein 
corona layer remained constant for each spiked solution, providing validation that only 
the composition of the corona was being altered upon increasing IgG in the bulk 
solution. Hence, at high IgG spiked concentrations, the protein layer would consist of 
a high proportion of IgG that would be tightly packed and randomly orientated within 
the corona, as depicted in Figure 7.09(b). Since the chiral fields of the nanostructures 
have been shown to be sensitive to the orientation and alignment of the adsorbed 
proteins, this would result in the decrease in the ∆∆𝑆 parameter value at the higher 
concentrations. 
When the ionic strength of the buffer, used to dilute the serum solutions, is increased 
by adding 150 mM NaCl to the Tris buffer, low concentrations of spiked IgG become 
undetectable. However, the higher 23.6% IgG spiked solution can be detected due to 
a shift in the limit of detection to higher concentrations. This occurs due to the 
electrostatic shielding of the higher ionic strength buffer between the proteins in 
solution and the charged binding surface, resulting in a lower coverage on the surface 
by the protein corona. Hence, with the electrostatic shielding from the Tris-saline 
buffer, the effective concentration of IgG in the protein corona is lowered. Resulting 
in the 23.6% IgG spiked serum solution in Tris-saline buffer, eliciting the same 
response in the ∆∆𝑆 parameter as a 16.5% IgG spiked serum solution diluted in Tris 
buffer only. 
In summary, we have demonstrated in this chapter, that a quantitative analysis of the 
IgG content in human serum solutions can be achieved experimentally using the ΔΔS 
parameter introduced in chapters 5 and 6. The levels of elevated IgG in the serum 
solutions can be detected for very low concentrations when diluted in Tris buffer, and 
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high concentrations well outside of the ‘normal’ patient range by increasing the ionic 
strength of the dilution buffer. This allows us to push the levels of detection possible 
into the appropriately high IgG range, and shows that elevated concentrations of IgG 
can be selectively detected in human serum solutions. This is the first demonstration 
of this phenomena being applied to a complex protein solution, such as human blood 
serum, and shows a new paradigm for detecting and quantifying elevated IgG levels 
at the physiologically high concentrations necessary in a clinical environment.  
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Summary and Future Outlook 
This thesis has presented a series of experiments detailing the use of chiral 
metamaterials for ultrasensitive biosensing measurements. This builds upon the 
previous work produced, in developing a high throughput injection moulding method 
for creating nanopatterned plasmonic substrates, and utilises these substrates for 
biosensing applications with ideal and complex protein solutions. In this section, we 
will provide a brief summary of the results presented in chapters 4 to 7, and consider 
where this work may be expanded in future applications. 
In the first results chapter, chapter 4, we build upon previous work where different 
structural motifs of proteins were discriminated using chiral structures that exhibit 
electromagnetic fields that possess a greater chiral asymmetry than circularly 
polarised light, termed ‘superchiral’. We investigate the sensitivity of these superchiral 
field enhancements to ligand induced conformational changes of proteins adsorbed 
onto the nanostructure surface. Two proteins from the Shikimate pathway, a seven-
step metabolic pathway found in plants and bacteria, were used due to each protein 
exhibiting a well characterised conformational change in their higher order structure 
upon specific ligand binding. To characterise these changes, optical rotatory 
dispersion spectra were measured, and the changes characterised using the 
asymmetry parameter ∆∆𝜆. With this parameter essentially measuring the changes in 
the effective refractive index on the asymmetry of the generated chiral fields. Utilising 
this ‘superchiral polarimetry’, which effectively measures the spectral position 
dependence of the plasmonic resonance on the dielectric environment surrounding 
the nanostructure surface, we show that the sensitivity of this phenomenon is 
increased relative to conventional chiroptical techniques, such as circular dichroism 
(CD). Since conventional circular dichroism can routinely only detect changes in the 
secondary and, to a much lesser extent, tertiary structure of proteins, the 
conformational changes induced for these two sample proteins are undetectable with 
CD spectroscopy. Hence, due to the anisotropy change of the protein structure upon 
these conformational changes, this phenomenon produces a highly sensitive probe 
for observing higher order changes in surface immobilised protein molecules. 
In chapter 5 of this thesis, we introduced two new parameters for characterising the 
changes observed upon the addition of biological samples to the nanostructure 
surface. The experimentally observed parameter, ∆∆𝑆, and the modelled parameters 
for retardation phase changes, ∆∆𝜃 and ∆∆𝜙. To extract these parameters, 
reflectance measurements were recorded for the chiral shuriken structures, which 
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exhibited electromagnetically induced transparency (EIT) like behaviour. This 
plasmonic analogue of EIT is a result of the interference between bright and dark 
hybrid plasmonic modes, with the strength of this coupling affecting the optical 
properties of the metamaterial. Small protein molecules consisting of the same 
scaffold, called Affimers, were immobilised onto the nanostructured surface with three 
different well-defined orientations. By utilising the experimental ∆∆𝑆 parameter, one 
orientation of the Affimer molecules could be distinguished, with the two others 
producing similar responses. However, when the reflectance spectra were modelled 
with a simple coupled oscillator model, the two retardation phase changes ∆∆𝜃 and 
∆∆𝜙 could be extracted. With these two retardation phase parameters being shown 
to be a more incisive probe into the orientation of the Affimer molecules at the 
nanostructure surface. 
In chapter 6, we continue using the ∆∆𝑆, and two retardation phase parameters 
introduced in chapter 5. However, here we utilised these phenomena to discriminate 
between two different immobilisation orientations of the cancer relevant protein, 
HSP90, as well as detecting any ligand induced conformational changes upon the 
addition of a well-known inhibitor molecule. By immobilising the same protein with two 
different orientations, we were able to show how the orientation of the immobilised 
molecule effects the sensitivity of the ligand induced changes detected. The 
experimental and modelled parameters used to characterise the differences, in the 
same was as chapter 5, showed very good agreement in the ligand induced changes 
detected. With one orientation of the immobilised protein exhibiting a higher sensitivity 
to the initial binding event of the inhibitor molecule. However, even though the 
experimental and modelled parameters were in agreement, the retardation phase 
phenomena was proved once again to be a more incisive probe into the ligand 
induced conformational changes of HSP90. With the modelled phase parameters 
detecting the final closure of the HSP90 molecule for one orientation, that was below 
the detection limit of the experimental ∆∆𝑆 parameter. 
Finally, in chapter 7, we moved from detecting protein differences in ideal purified 
solutions, to the ultimate objective of using complex protein solutions, such as human 
blood serum. Human blood serum contains more than 20,000 different proteins, 
varying in concentrations from 50 g/L to less than 1 ng/L, with an overall concentration 
of ~1 mM, making it an extremely complex solution to characterise. The experimental 
∆∆𝑆 parameter was used to quantify any changes in the protein corona when elevated 
levels of IgG were spiked into the serum solutions. By utilising as anionic ligand on 
the nanostructure surface, the amount of IgG adsorbed in the protein corona could 
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be enhanced relative to other proteins, due to IgG being the only abundant protein 
present in the serum solutions with an isoelectric point over 7. When the amount of 
IgG in the serum samples was increased, only the composition of the protein corona 
layer was altered, with the coverage on the nanostructure surface remaining the same 
between different concentrations of IgG spiked serum solutions. However, when the 
serum solutions were diluted in Tris buffer, at high IgG spiked concentrations, the 
concentration of IgG present in the protein corona also increased. With the IgG in the 
corona being tightly packed and randomly orientated relative to the nanostructure 
surface. Resulting in it becoming increasingly difficult to separate serum solutions 
consisting of different elevated IgG concentrations. To address this problem, the ionic 
strength of the solutions was increased by adding 150 mM NaCl to the dilution buffer. 
With the electrostatic shielding of the higher ionic strength buffer lowering the 
coverage of the protein corona on the nanostructure surface, due to the shielding of 
the electrostatic interactions between the anionic monolayer and the proteins in 
solution. The result of this lower coverage meant that lower effective concentrations 
of IgG were present in the corona relative to the bulk solution, allowing the IgG to 
orientate freely, and increasing the level of elevated IgG detected into the 
physiologically relevant levels necessary for clinical applications. 
The preliminary results shown throughout this thesis demonstrate the sensitivity of 
these phenomena to the structure and orientation of protein molecules at the 
nanostructure surface. By using complex protein solutions, such as human serum 
solution, we have demonstrated, for the first time, the ability of using high-throughput 
injection moulded metamaterials for creating a commercially viable biosensing 
system. In progression from the initial observations detailed throughout this thesis, 
further investigation into the detection ability in complex protein systems, as well as 
characterising structural properties on the mesoscale (such as viruses), would be key 
objectives for any future work. With the ultimate goal of creating a high-throughput 
biosensing system, suitable for diagnostic characterisation in a clinical environment.  
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Appendix A – Plasmonic EIT Modelling 
A.1   Modelling Function 
The basis of the model used to fit the plasmonic induced transparency spectra within 
this thesis was first proposed by Zhang et al. [1] and subsequently used by Tassin et 
al. [2]. This coupled oscillator model describes the system by the equations: 
𝜔2
−2?̈?(𝑡) +  𝛾𝑟𝜔𝑟
−1?̇?(𝑡) +  𝑝(𝑡) =  𝑔𝑓(𝑡) − ?̃?𝑞(𝑡) 
𝜔𝑑
−2?̈?(𝑡) +  𝛾𝑑𝜔𝑑
−1?̇?(𝑡) +  𝑞(𝑡) =  −?̃?𝑝(𝑡) 
In these equations, the radiative (bright) resonator is described by the excitation 𝑝(𝑡), 
with a resonance frequency 𝜔𝑟, and damping factor 𝛾𝑟. Equally, the dark mode 
excitation is described by the excitation 𝑞(𝑡), with a resonance frequency 𝜔𝑑, and a 
damping factor 𝛾𝑑. The two resonators are coupled by a complex coupling constant 
?̃?, with the bright mode being driven by an external force 𝑓(𝑡), and a constant, 𝑔, 
indicating the coupling strength between the oscillator and the external force. 
Equations A.1.1 and A.1.2 are solved by assuming the following solutions to these 
equations: 
𝑝(𝑡) =  𝑒−𝑖𝜃𝑃(𝜔)𝑒−𝑖(𝜔𝑡) 
𝑞(𝑡) =  𝑒−𝑖𝜙𝑄(𝜔)𝑒−𝑖(𝜔𝑡) 
As the coupling depends on the phase difference between the two oscillators, it can 
be considered that ?̃? =  𝑘𝑒−𝑖(𝜃−𝜙). Solving equations A.1.1 and A.1.2 for the solutions 
shown in A.1.3 and A.1.4 gives the following relations: 
𝑃(𝜔)𝑒−𝑖𝜃 =  
𝑔𝐹(𝜔) −  ?̃?𝑄(𝜔)𝑒−𝑖𝜙
𝐷𝑟
 
𝑄(𝜔)𝑒−𝑖𝜃 =  
−?̃?𝑃(𝜔)𝑒−𝑖𝜙
𝐷𝑑
 
Where 𝐷𝑑 =  1 − (
𝜔
𝜔𝑑⁄ )
2
−  𝑖𝛾𝑑
𝜔
𝜔𝑑⁄ , and 𝐷𝑟 = 1 − (
𝜔
𝜔𝑟⁄ )
2
−  𝑖𝛾𝑟
𝜔
𝜔𝑟⁄ . 
By substituting equation A.1.6 into equation A.1.5, it becomes: 
𝑃(𝜔) =  
𝑔𝐷𝑑(𝜔)𝐹(𝜔)
𝑒−𝑖𝜃(𝐷𝑟(𝜔)𝐷𝑑(𝜔) − 𝑘2𝑒−2𝑖
(𝜃− 𝜙))
 
 
(A.1.1) 
(A.1.2) 
(A.1.3) 
(A.1.4) 
(A.1.5) 
(A.1.6) 
(A.1.7) 
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The susceptibility is then calculated from equation A.1.7 using: 
𝜒(𝜔) =  
𝑃(𝜔)
𝐸(𝜔)
 
Where 𝐸(𝜔) =  𝐹(𝜔), and hence susceptibility becomes: 
𝜒(𝜔) =  
𝑔𝐷𝑑(𝜔)
𝑒−𝑖𝜃(𝐷𝑟(𝜔)𝐷𝑑(𝜔) −  𝑘2𝑒−2𝑖
(𝜃− 𝜙))
 
Since the plasmonic system being modelled here is based on a continuous metallic 
film, rather than individual nanostructures on a transparent substrate, this needs to 
be catered for through an effective medium approach. The average of the 
susceptibility from the plasmonic system and the gold film can then be calculated. 
𝜒𝐴𝑣𝑔(𝜔) =  
𝜒(𝜔) +  𝜒𝐴𝑢
2
 
In equation A.1.10, 𝜒𝐴𝑢 is the susceptibility of gold. As the refractive index can be 
calculated by taking the square root of the permittivity, and the susceptibility is directly 
related to the permittivity, the refractive index can be calculated as: 
𝑛𝐸𝐼𝑇 =  √𝜒𝐴𝑣𝑔(𝜔) + 1 
From this refractive index, and the refractive index of the solution (𝑛𝑆𝑜𝑙), the reflectivity 
can be calculated by: 
𝑅𝑒𝑓𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =  |(
𝑛𝑆𝑜𝑙 −  𝑛𝐸𝐼𝑇
𝑛𝑆𝑜𝑙 +  𝑛𝐸𝐼𝑇
)
2
| 
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(A.1.8) 
(A.1.9) 
(A.1.10) 
(A.1.11) 
(A.1.12) 
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Appendix B – Experimental 
B.1   Shuriken Symmetry and Hybridisation 
Character table for structures consisting of C6 symmetry is shown in Table B.01 
 
Table B.01 C6 symmetry character table. 
 
B.2   Plasmonic EIT Modelling Method 
To obtain the modelled spectra for each reflectance measurement, ten variables 
(described in chapter 3) were initially allowed to vary for the water/buffer spectra. 
These were varied by small amounts to achieve the best quality fit for the reference 
spectra, and stopped when changing the values were detrimental to the fit. These 
parameters were then carried forward in the model for the protein absorbed spectra, 
with only the five parameters, 𝜔𝑟, 𝜔𝑑, 𝑘, 𝜃, and 𝜙, being varied. These five parameters 
were again varied by small amounts to achieve the best fit, until no improvement could 
be made by altering the parameter values. This was repeated three separate times 
on the experimental data for each experiment, with the average values and standard 
errors being calculated for each of the five parameters in the modelled spectra. 
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Appendix C – Detection of Higher Order Structural 
Changes 
C.1   Protein and Ligand Concentrations 
Both EPSP synthase and shikimate kinase were purified as described in chapter 3. 
With the protein concentrations obtained being 20.0 mg/ml for EPSP synthase, and 
7.7 mg/ml for shikimate kinase. HEPES buffered saline (10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, and 150 mM NaCl) solution, pH 7.2, was used to make 
all ligand solutions. The EPSP synthase ligand solution was made up of 15 μM 
shikimate-3-phosphate (S3P) and 5 μM glyphosate. With the shikimate kinase ligand 
solutions consisting of 0.6 mM ADP, 2.0 mM shikimic acid, and 2.0 mM MgCl2. 
The ORD measurements were recorded in the presence of buffer after surface 
functionalisation, as a reference measurement, and then the protein solution was 
added to the surface and left to incubate at room temperature for 1 hour. Once the 
protein had adsorbed to the NTA/EG-thiol SAM, the protein solution was rinsed from 
the sample several times with buffer, and then further ORD measurements were 
recorded. Next, the appropriate ligand solution was added to the adsorbed proteins 
on the substrate surface, and left to incubate for 30 minutes before the final ORD 
measurements were recorded. All ORD measurements were recorded in the 
presence of 10 mM HEPES buffered saline (HBS) solution. 
 
C.2   Ligand Only Solution ORD and Average Shifts 
ORD spectra for respective ligand only solutions, in the absence of any adsorbed 
proteins, are shown in Figure C.01. The shifts shown for the ligand only solution, in 
the absence of protein, for the ORD spectra and in Figure C.01(b) are very small 
relative to the changes occurring for the proteins. The much larger shifts caused by 
the adsorption of the protein, and addition of the ligand solution to the adsorbed 
protein, compared with the ligand only solution is due to the protein being much larger 
than the ligands, and so will increase the refractive index of the region surrounding 
the nanostructures more than the ligand solution alone. When the respective ligand 
solutions are added to the immobilised proteins, in the case of EPSP Synthase, there 
is a decrease in the average shift as seen in Figure C.01(b). This is consistent with 
the conformational change expected, as the two domains close upon ligand binding, 
there is a reduction in the volume of the protein causing the decrease in average shift.     
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Figure C.01 (a) ORD spectra for EPSP Synthase (top), and shikimate kinase (bottom) ligand 
solutions relative to initial buffer measurements for left- (red) and right-handed (blue) shuriken 
structures. The solid and dashed lines represent the initial buffer measurement, and ligand 
solution measurements respectively. (b) The average shifts measured for EPSP Synthase 
and shikimate kinase when the protein was immobilised, when the ligand solutions were 
added to adsorbed proteins, and ligand solutions only in the absence of adsorbed protein. The 
error bars represent the standard error calculated from 8 spectra measurements.  
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Appendix D – Immobilisation and Results of Affimer 
Proteins 
D.1   Immobilisation  
All Affimer solutions were obtained from Avacta life sciences, and diluted to a 
concentration of 1 mg/ml in 10 mM HBS solution before being added to the substrate. 
The three Affimers received from Avacta, and their initial concentrations were: two 
glutathione S-transferase (GST) binding variants; G65C (1.5 mg/ml) and K67C (2.0 
mg/ml), and one immunoglobulin G (IgG) binding variant; H6C (4.4 mg/ml). The 
concentrations of the target protein solutions, GST and IgG, added to the surface 
bound Affimers, were 0.8 mg/ml in each case. 
To immobilise the Affimers onto the gold surface, the Affimer solution was added to 
the substrate and left to incubate at room temperature for 2 hours. This solution was 
then rinsed in 10 mM HBS. The surface was then ‘back-filled’ with a 10 μM Triethylene 
glycol mono-11-mercaptoundecyl ether solution in 10 mM HBS, and left to incubate 
at room temperature for 1 hour. This was then again completely rinsed off with 10 mM 
HBS before the target protein was added. The respective protein solutions were then 
added to the immobilised Affimer surface, and left to incubate for 1 hour before being 
rinsed off with 10 mM HBS solution to remove any unbound protein. All experimental 
measurements were recorded after the substrate had been rinsed, and in the 
presence of 10 mM HBS. 
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D.2   ORD Results  
ORD were recorded using the exact same methods as described in chapter 3, and 
used in chapter 4.  
 
Figure D.01 ORD spectra for the three Affimer variants. (a) H6C, (b) G65C, and (c) K67C. 
Also (d) shows the ∆∆𝜆 values for each Affimer for peak 1 of the ORD spectra.  
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D.3   Chiral Simulation Modelling Results  
The chiral dielectric simulations were performed by Dr Affar Karimullah, using the 
Wave Optics module in COMSOL Multiphysics v4.4, a commercial finite element 
package. 
The simulated data modelling parameters are shown in Table D.01. In the 
simulations, the left- and right-handed nanostructures have identical reflectivity 
spectra with water, and hence will have identical fitting parameters. The ∆∆𝜆 values 
shown in Table D.01, show a significant asymmetry in 𝜃 and 𝜙. 
 
Table D.01 Fitting parameters for the reflectivity of the simulated spectra with water (identical 
for left- and right-handed nanostructures, and a chiral dielectric for both left- and right-handed 
structures. 
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Appendix E – Immobilisation HSP90 Protein 
E.1   Protein and Ligand Concentrations 
The HSP90 proteins were purchased from both Sigma Aldrich (C-terminus His-tag) 
and Enzo life sciences (N-terminus His-tag). Both variants of the protein were diluted 
to 0.1 mg/ml concentration, in 10 mM HEPES buffered saline (HBS), before being 
added to the nanostructured surface. To create the ligand solutions, 17-(Allylamino)-
17-demethoxygeldanamycin (17-AAG) was dissolved in dimethyl sulfoxide (DMSO) 
to a total concentration of 20 μM. This was then diluted in HBS buffer to give ligand 
solutions with total concentrations of 1 nM, 10 nM, 100 nM, 1μM, and 10 μM. The 
control solutions of DMSO in buffer were prepared using the same volumes as above 
but without any 17-AAG inhibitor added.  
The reflectance measurements were recorded in the presence of buffer after surface 
functionalisation, as a reference measurement. The protein solution was then added 
to the surface, and left to incubate at room temperature overnight (~17 hours). This 
was then rinsed with buffer several times, and further measurements recorded. After 
this, increasing concentrations of ligand solutions, from 1 nM to 10 μM in 1 order of 
magnitude steps, were added consecutively to the immobilised protein and allowed 
to incubate for 30 minutes before reflectance measurements were recorded. All 
reflectance measurements were recorded in the presence of 10 mM HBS solution.  
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E.2   Modelling Values 
Tables E.01 and E.02, show the numerical values for modelling of the HSP90 
proteins with the ligand addition for the C-terminal His-tagged, and N-terminal His-
tagged protein respectively. 
 
Table E.01 Modelling values for the five variable parameters for the immobilisation of HSP90, 
and after the addition of each ligand solution for the C-terminal His-tagged protein. 
 
Table E.02 Modelling values for the five variable parameters for the immobilisation of HSP90, 
and after the addition of each ligand solution for the N-terminal His-tagged protein.  
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Appendix F – Human Serum Solutions 
F.1   Serum solution preparation 
Lyophilised human blood serum proteins (ERM© certified reference material) was 
purchased from Sigma Aldrich and diluted in distilled water to create a stock serum 
solution with a total protein concentration of 60 mg/ml. Serum solution, both spiked 
and unspiked, were produced with concentrations ranging from 3x10-4 to 3 mg/ml 
were produced by diluting the stock serum solutions with either 10 mM Tris buffer, or 
10 mM Tris-saline buffer containing 150 mM sodium chloride (NaCl), both at pH 7.4. 
The spiked serum samples were produced by adding the relevant protein to the stock 
serum solution diluted to 3 mg/ml. The spiked IgG solutions were produced by adding 
0.025, 0.050, 0.100, 0.175, and 0.250 mg of the protein per ml of serum solution 
diluted to 3 mg/ml. With lyophilised IgG from human serum being purchased from 
Sigma Aldrich. Subsequently, a further amount of relevant buffer was added to each 
spiked solution to give different spiked concentrations that each have a total protein 
concentration of 3 mg/ml. This provided solutions with 16.1%, 17.0%, 18.6%, 21.1%, 
and 23.6% IgG by mass. Transferrin, albumin, and IgG spiked serum solutions were 
produced by adding 0.050 mg, or 0.250 mg in the case of saline buffer diluted 
samples, of respective protein per ml of stock serum solution, once again diluted to 
give an overall concentration of 3 mg/ml for each spiked protein solution. All spiked 
solutions were then diluted with the relevant buffer to produce the required protein 
concentration solution between 3x10-4 and 3 mg/ml. It should be noted that, since 
serum solution contains saline at ~150 mM, the solutions diluted in Tris buffer 
containing no NaCl will still have a small saline concentration ranging from ~0.75 μM 
to 7.5 mM. In contrast to the solutions diluted in Tris buffer containing 150 mM NaCl, 
which will have a saline concentration of ~150 mM to 157.5 mM. Therefore, the saline 
buffered solutions have a considerably higher ionic strength than the serum solutions 
alone. 
The reflectance measurements were recorded in the presence of buffer after surface 
functionalisation, as a reference measurement. The serum solutions were then added 
to the surface, and left to incubate at room temperature for 20 minutes before the 
results were recorded. This was repeated for each consecutive measurement of 
increasing total protein concentration for each spiked solution. Therefore, the saline 
buffered solutions have a considerably higher ionic strength than the serum solutions 
alone. 
